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Summary 
 
This thesis will present an introduction to cellular and molecular adaptation to loading 
and unloading of skeletal muscle, whilst exploring the advantages and disadvantages 
of current techniques employed in the field of exercise biochemistry. In response to 
the current techniques used to assess the signal transduction and protein changes 
present in response to loading and unloading, we propose a potential, novel method 
of assessing whole, murine skeletal muscle protein isoforms via flow cytometry. In 
addition to this, this thesis also explores the changes in morphology and myonuclear 
number within skeletal muscle following varying periods of atrophy, and recovery from 
atrophy produced in response to tetrodotoxin administration to silence a motor nerve 
and therefore muscular contraction in the ankle dorsiflexor muscles of the rat hindlimb.   
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Chapter 1: An introduction to skeletal muscle adaptation to loading and unloading. 
Hypertrophy Signalling Pathways 
Chronic strength training brings about adaptive responses that allow skeletal muscle to meet 
the demands of future bouts of resistance training. Typically, this results in increased muscular 
hypertrophy (an accumulation of myofibrillar proteins, subsequently increasing muscle cross 
sectional area) and strength, if protein synthesis increases to a greater extent and duration 
than degradation (Phillips, 2014; Wackerhage & Ratkevicius, 2008).  Armstrong et al., (1993) 
in rodents and Roth et al., (1999) in humans reported that performing eccentric strength 
training caused localised disruption of normal myofibrillar banding patterns. For the myofibril 
to reconstitute its functional contractile state and adapt to future bouts of resistance, 
myofilaments must be repaired or replaced as the body continually turns over proteins in a 
state of positive net protein balance (Phillips, 2014; Yin et al., 2013). This remodelling process 
can alter dependent on whether the muscle is eccentrically or concentrically loaded (Franchi 
et al., 2017). However, it seems that both eccentric and concentric loading follow the same 
mechanotransduction pathway in order to activate the anabolic mTOR signal transduction 
pathway to increase protein synthesis, thus levels of hypertrophy are generally found to be 
the same between contraction types, if total volume of load is the same (Franchi et al., 2017), 
despite the large variance in loading experienced between eccentric, concentric and co-
contraction models (Schmoll et al., 2017). The only resultant difference in remodelling 
following these different contraction states may be where new protein is laid down (eccentric-
in series, concentric- moreso in parallel), the actual protein content and remodelling of the 
extra-cellular matrix/stem cell niche, as opposed to changes in total protein content (Franchi 
et al., 2017; Hyldahl et al., 2015; Jakobsen et al., 2018). 
Since its discovery in the early 1990’s by Schreiber & Sabatini (Brown et al., 1994; Sabatini et 
al., 1994), mechanistic target of rapamycin (mTOR) has been recognised as the key nutrient, 
energy and redox status sensor within eukaryotic cells responsible for controlling protein 
synthesis. mTOR itself exists in two protein complexes; mTORC1 and mTORC2 which are 
associated with different locations within a cell and phosphorylation of different proteins. In 
relation to resistance exercise, Baar and Esser, (1999) identified that mTORC1 signalling 
cascade was activated by electrically stimulated, resistance exercise in a rodent model. 
mTORC1 can directly phosphorylate S6K1 on a hydrophobic motif site, Thr389 allowing for 
phosphorylation and activation by PDK1; the activation of which promotes ribosomal 
biogenesis, mRNA translation initiation and also phosphorylates 4EBP which results in 
increased translation efficiency (Saxton & Sabatini, 2017), The amount of p70s6k 
phosphorylation was found to be directly related to the degree of hypertrophy (Baar and Esser, 
1999).  
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The actual pathway responsible for the signal transduction of mechanical stimuli to a 
biochemical signal, termed mechanotransduction is still not largely understood due to an 
unidentified mechanoreceptor which inhibits tuberous sclerosis complex 2 (TSC2), resulting 
in the activation of Rheb and mTOR. Research by the Hornberger group has illustrated that 
this mechanically stimulated increase in mTOR activation may occur through a mechanism 
that requires phosphatidic acid and a phosphatidic acid synthesising enzyme called 
diacylglycerol kinase zeta (DGKζ) (Hornberger et al., 2006). Muscles deficient in the DGKζ 
enzyme have a reduced capacity to activate mTOR by up to 50% (You et al., 2014; You et al., 
2018). Protein co-localisation studies have revealed that following resistance exercise, mTOR 
co-localises with late endosomal-lysosomal system (Jacobs et al., 2013), that have recently 
been reported to contain high levels of phosphatidic acid and Rheb (Zhange et al., 2013). 
Furthermore, prior to resistance exercise Rheb’s ability to activate mTOR is inhibited by TSC2 
and TSC2 is found to be co-localised with Rheb. Following resistance exercise, this 
association with TSC2 with the LEL is removed, therefore allowing for activation of mTOR 
(Jacobs et al., 2013; Jacobs et al., 2017; Sawan et al., 2018; Song et al., 2017).  With 
advancements in proteomics and phosphoproteomics, it is expected that this 
mechanotransduction pathway will continue to be uncovered (Potts et al., 2017). 
However, the degree to which muscle hypertrophies may also be interrupted through the 
molecular responses present when resistance exercise is combined with endurance exercise. 
Specifically through elevated AMP levels and AMPK phosphorylation levels which have 
previously been negatively correlated with skeletal muscle hypertrophy and protein synthesis 
after acute bouts of concurrent training (Bodine et al., 2001; Bolster et al., 2002; Katta et al., 
2012; Thomson et al., 2008). Genetic knockout of AMPK results in greater hypertrophy 
(Mounier et al., 2009), by preventing direct phosphorylation of TSC2, thus preventing Rheb’s 
activation of mTOR and downstream cascade of protein translation and synthesis (Inoki et al., 
2002). This mechanism may be to potentially prevent muscle protein synthesis and growth 
when energy is required elsewhere. 
 
Hyperplasia 
A less common phenomenon found within human physiology of increasing muscle size is 
termed 'hyperplasia', the increase in number of individual muscle fibres. Whilst numerous 
animal models have previously shown that supra-physiological loading, synergist ablation and 
denervation can result in an increase in number of fibres and/or cause fiber branching or 
splitting in an overloaded muscle (Antonio & Gonyea, 1993, 1994; Ho et al., 1980; Tamaki et 
al., 1992), the mechanisms and exact stimulus resulting in this are yet to be elucidated. This 
in part due to the following methodological issues: 1; Histological analysis is often constrained 
to a biopsy sample of a muscle, and therefore may not be representative of the whole muscle 
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due to the huge variations in fiber architecture and composition of fiber types across different 
heads of multipennate muscles, 2; The phenomenon of fibre splitting would convey a false 
increase in fibre number when assessed via histological cross-sections. However, if fibre 
bundles from skeletal muscle were separated into individual myofibers using gentle 
collagenase treatment, it would be observed that fibers actually split and branch out as 
opposed to becoming a completely new muscle fiber (Antonio & Gonyea, 1993, 1994). Whilst 
under certain conditions of mechanical stretch and overload skeletal muscle hyperplasia has 
been shown to occur, albeit mostly in animal models, the mechanisms behind this have yet to 
be explored and have seemingly received very little recent attention in the field of skeletal 
muscle adaptation. This may be due to the fact that the only way of truly establishing whether 
hyperplasia has occurred is by assessing the number of fibres across the whole muscle as 
opposed to a biopsy and to extract the tissue at a timepoint where this occurs. Whilst this is 
clearly not possible in humans, advancements in in-vivo imaging techniques with animal 
models (Bruusgaard & Gundersen, 2008), may one day make the investigation into the exact 
stimulus and process possible.  
 
Satellite cells and their contribution to muscle regeneration  
Skeletal muscle repair following eccentric damage is a complex mechanism attributed not only 
to the balance of protein synthesis and degradation, but also involves the confluence of both 
the activation and differentiation of satellite cells-specific to muscular lineage, adding 
additional myonuclei to existing myotubes or if the stress is severe enough causing formation 
of ‘de novo’ myofibers by satellite cells fusing together; producing hypertrophy (Knapp et al., 
2015). Satellite cells are mononucleated, multipotent, myogenic pre-cursor cells and are the 
local source of repair, regeneration and growth following myofibrillar damage in post-natal 
mammals, ensuring that mechanical, structural and functional integrity of skeletal muscle is 
maintained following exercise or injury (Hawke and Garry, 2001).  
 
Satellite cells represent the primary pool of stem cells resident within adult skeletal muscle 
and are responsible for both muscle fibre repair and generation of new myofibers 
(hyperplasia); both of which contribute to hypertrophy. Satellite cells located in a quiescent 
state beneath the basal lamina of the myofiber, have the capacity once activated to proliferate, 
differentiate and fuse to damaged myofibers to carry out regeneration/repair of muscle tissue 
and for hypertrophy to occur following resistance training (Hawke and Garry, 2001). Despite 
the paucity of satellite cells associated with an individual myofiber, making up just 2.5-6% of 
fiber nuclei, they can be rapidly activated to restore exercise-induced damage (Zammit et al., 
2004). Specifically, the processes following exercise-induced muscle damage are brought 
about by a family of proteins known as myogenic regulatory factors (MRF) (Nederveen et al., 
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2017). Firstly, to become activated following exercise or damage, a cascade of cell signaling 
occurs bringing about the release of growth factors such as HGF, MGF, IGF-I and FGF2 which 
then bind to receptors present on the quiescent satellite cell, thus activating it (Hill et al., 2003a; 
Pelosi et al., 2007). Activated satellite cells initially express two MRFs, myogenic differentiation 
factor (MyoD1) and Myogenic factor 5 (Grobler et al., 2004); which are expressed at extremely 
low levels during quiescence (Rudnicki et al., 1993). From this point, satellite cells can 
proliferate via upregulation of the transcription factor paired box protein 7 (Pax7), without 
which satellite cell lineage would be lost (Von Maltzahn et al., 2013), or return to a state of 
quiescence where MyoD1 will be downregulated and the population of satellite cells restored 
(Baumert et al., 2016).  
 
Alternatively, when tasked to repair damaged myofibers, satellite cells withdraw from the cell 
cycle and differentiate, accompanied by the upregulation of herculin and myogenin (Arnold 
and Braun, 2003; Miner and Wold, (1990). Myoblasts differentiate into myocytes which migrate 
along chemotactic gradients to the injured myofibers and support the repair by increasing the 
number of active myonuclei of existing fibres and thus, providing support to the larger 
cytoplasmic volume (Egner et al., 2016). However, if the extent of damage is too large to repair 
or involves the destruction and removal of the existing fibres via macrophages, the 
differentiated myocytes fuse with other myogenic cells forming myotubes, producing new ‘de 
novo’ myofibers replacing the damaged fibres (Tidball, 2011).  
 
Processes such as ageing, dystrophies and physical inactivity have a negative impact on 
skeletal muscle repair due to the significant reduction in regenerative capacity; attributed to 
the decreased ability of satellite cells to proliferate, occurring in adulthood and declining further 
still in the elderly populations. Much of the loss in proliferative ability in adulthood and the 
switch to reliance on remodeling and hypertrophy of existing fibres is due to the long lifespan 
of satellite cells, therefore making satellite cells vulnerable to accumulation of cellular damage, 
causing a reduction in their capability to self-renew, as well as the whole muscle itself. The 
eventual outcome of this is reduction in the satellite cell pool and debilitating changes in their 
resident microenvironment, therefore delaying or reducing capability of skeletal muscle repair 
following exercise or severe injury. (Billin et al., 2016; Chandel et al., 2016; Fehrer and 
Lepperdinger, 2005). However, the significant loss of muscle mass, strength and quality of life 
associated with skeletal muscle ageing (sarcopenia) can be reduced through appropriate 
nutrition and hormonal adaptations to exercise (Morley et al., 2010). Current 
recommendations to promote healthy ageing include resistance and aerobic exercise, 
combined with a leucine-rich protein diet; both of which are key in upregulating mTOR signal 
transduction pathways which increase protein synthesis and activating satellite cell pathways 
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which aid in acute repair of damaged myofibers and long-term hypertrophy (Campbell and 
Leidy 2007; Johnston et al., 2007). Therefore, developing a better understanding of the 
proliferative capacity and differentiation of satellite cells following different stimulation patterns 
will help designate appropriate intervention for repair of injured muscle and reduction in 
disease-related or ageing muscle wastage. Alongside this, there is the potential to identify 
specific training patterns that avoid excessive ‘endurance like’ stimuli, or even ‘overtraining in 
which damage occurs rather than repair, amplifying hypertrophy for both sports performance 
and the increasing ageing population (Johnston et al., 2007).  
 
Although Lepper et al., (2011) confirming that elimination of Pax7+ cells through genetic 
ablation completely blocks regeneration of any myofibers following acute injury in mice, fully 
functional, regenerative myogenesis requires the interaction of multiple cell types including 
fibroblasts, not surprisingly due to the abundance of connective tissue fibrosis often occurring 
around the site of severe myofiber injury (Mackey et al., 2017). Understanding these 
myogenic-fibroblast interactions is essential to help prevent impaired healing, especially in the 
elderly who characteristically have a higher abundance of fibroblasts, which subsequently 
replace contractile proteins with fibrous/fatty scar tissue, resulting in loss of strength and an 
increased risk of falling and frailty (Maddaluno et al., 2017; Morley et al., 2010). 
 
In-vivo studies from Murphy et al., (2011), utilizing a mouse model whereby genetic insertion 
allows targeted destruction of Pax7+ and Tcf4 cells, through tamoxifen injection which 
activates Cre, which subsequently activates diphtheria toxin A ablating Pax7+ and Tcf4 cells. 
Injury following the ablation of satellite cells causes misregulation of Tcf4 fibroblasts to the 
extent that expansion of fibroblasts was reduced by 52%. Contrastingly, ablation of Tcf4 
fibroblasts caused a 51% reduction in Pax7 satellite cells 5 days post injury coupled with a 
79% reduction in MyoD+ Pax7 satellite cells, indicating a large decrease in differentiating 
myoblasts. Partial ablation of Tcf4 fibroblasts results in premature differentiation of satellite 
cells to myoblasts giving rise to smaller regenerated myofibers post injury. Mathew et al., 
(2011) also demonstrated the significance of reciprocal interactions connective tissue 
fibroblasts and satellite cells have in a fibroblast/myoblast trans-well culture. Cultured 
myoblasts alone differentiated into multinucleate myofibers, however with the addition of 
fibroblasts in the same culture, myotube fusion index significantly increased (p<0.0001, 10 vs. 
40 with fibroblasts). Mackey et al., (2017) also produced electrically stimulated eccentric 
damage in humans and showed that there was a clear preferential association of fibroblasts 
with regenerating myofibers and new myofibers with central nuclei, in comparison to 
undamaged myofibers; with 104 ± 6.23 fibroblasts per mm2 after injury and 26 ± 3.14 
fibroblasts per mm2 in the uninjured limb. Whilst the interactions between satellite cells, 
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fibroblasts and the extracellular matrix are still being understood, as well as 
mechanotransduction pathways, it is clear that in reality, maintenance/growth of healthy 
muscle mass is controlled by a complex combination and interaction of the anabolic mTOR 
signaling pathway and satellite cell interactions which are yet to be elucidated. 
 
Chapter 2: An overview of methods used in exercise biochemistry. 
 
As outlined in the first chapter, exercise biochemistry is the study of the signal transduction 
mechanisms that lead to adaptation to exercise, whether it be hypertrophy following resistance 
training or mitochondrial associated protein changes following endurance training. Whilst 
measurement of adaptations to exercise have long been possible at the whole-body/organ 
level using non-invasive methods, the understanding of adaptation to exercise has been vastly 
improved due to the development of the muscle biopsy technique (Bergström & Hultman, 
1966), and use of biochemical methods in the past 30 years. This chapter aims to give a brief 
introduction into current biochemical techniques employed specifically by exercise 
biochemists, their applications and limitations of their use. 
 
RT-qPCR 
The polymerase chain reaction (PCR) was introduced by Kary Mullis in the 1980’s to amplify 
small DNA fragments in order to appropriately sequence it (Mullis, 1990). This has enabled 
genetic association studies and genome-wide association studies to link gene polymorphisms 
to abnormal expression of a gene or production of an irregular form of a protein. These 
abnormalities can be linked to disease and injury such as COL5A1 and its link to irregular 
extracellular matrix formation and increased risk of non-contact ligament injury (Posthumus et 
al., 2009; Zoppie et al., 2004). However, particular polymorphisms can be linked to good health 
and performance, such as the ACTN3 R577X genotype association with greater power in elite-
level athletes and greater hypertrophic responses to resistance exercise (Clarkson et al., 
2005; Yang et al., 2003). 
The technique has been further extended to measurement of gene expression through 
amplification and measurement of RNA (cDNA), therefore providing a method of 
understanding the signalling responses and cascades to various different exercise stimuli and 
nutrition that ultimately lead to adaptation. This method relies on the extraction and isolation 
of RNA, most popularly achieved through homogenisation of tissue combined with the reagent 
Trizol that contains phenol, chloroform and guanidinium thiocyanate. This solution allows 
tissue to become soluble, disrupting and dissolving cell components whilst effectively inhibiting 
RNase activity. Centrifugation of the Trizol treated homogenate results in separation into a 
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clear, upper aqueous layer which contains RNA, an interphase layer containing DNA and an 
organic phase containing proteins and lipids (Chomczynski & Sacchi, 1987). A solution 
containing only RNA can then be collected, washed with alcohol and the precipitate collected 
following centrifugation. RNA can then be quantified using spectrophotometry and is then 
usually converted to cDNA through reverse transcription and a reverse transcriptase enzyme.  
 
The specific cDNA is then amplified by a polymerase chain reaction consisting of 25-35 cycles 
of denaturation, annealing and extension using specific primers (short strands of RNA) 
designed to match specific genes of interest. During the thermal cycling of the PCR, a 
fluorescent reporter molecule/probe is measured using a fluorimeter and increases as the 
product accumulates through each amplification cycle. This quantitation of a transcript is then 
reported relative to changes in a reference gene (a gene that’s expression will not change 
between experimental conditions), therefore providing a semi-quantitative report of a genes 
expression (Wackerhage, 2014). 
Whilst gene expression (RNA present within the tissue of interest) can give us an 
understanding of the signals being transduced following a particular stimulus, e.g. load, the 
upregulation or downregulation of gene expression does not always lead to changes at the 
protein level. This is due to a number of factors including amino acid availability, post-
translational modifications and transcriptomic/epi-transcriptomic regulation of mRNA (Davalos 
et al., 2018; Wackerhage, 2014). Whilst this technique is important to elucidate mechanisms 
through which resistance/endurance training controls the expression of a gene, gene 
expression should not be used to conclude that a change in mRNA leads to a protein change 
and instead, should ideally be combined with data of the amount of a protein present after 
exercise/nutritional intervention as suggested by Miller et al., (2016). 
 
Western Blotting 
Western blotting, also known as immunoblotting is a process whereby proteins are separated 
in an electrical field and then detected and quantified (abundance) using specific antibodies 
for an antigen found on the protein of interest. As most signalling transduction is done by 
proteins and often involves post-translational modifications such as phosphorylation of 
proteins, western blotting provides a useful tool to investigate protein abundance and their 
modification in response to a specific stimulus (Bass et al., 2017). Similarly to RT-qPCR, 
western blotting is a semi-quantitative assay as the abundance of a protein is always 
measured relative to a reference protein such as GAPDH or to expression in another control 
tissue.  The process of western blotting first requires the extraction of protein from the tissue 
being investigated, usually achieved through homogenisation and treatment with Triton X-100, 
used as a detergent to lyse cells and release protein. The protein concentration in the resultant 
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supernatant is then quantified using a Bradford or Bicinchoninic acid assay (BCA) allowing for 
samples to be standardised to the same protein concentration. The supernatant is further 
treated with Laemlli buffer (Laemmli, 1970) in order to denature and negatively charge proteins 
with the anionic detergent sodium dodecyl sulfate (SDS). Samples are further heat denatured 
whilst in this solution at 95°C for 5 minutes allowing proteins to completely unfold whilst SDS 
binds with proteins preventing refolding of the protein when the supernatant is cooled (Bass 
et al., 2017). Proteins can then be separated using gel electrophoresis, a process whereby 
proteins are equally loaded into lanes within a gel and are pulled towards a positive electrode. 
The smaller the protein the faster it will travel through the gel therefore ordering proteins based 
on their atomic mass.  
These proteins can then be transferred to a nitrocellulose membrane where they can be 
probed at the correct molecular weight with a primary antibody that will bind selectively to a 
protein of interest. A secondary antibody then binds to the primary antibody and is conjugated 
to a fluorophore or enzyme (e.g. HRP) for visualization with a fluorometer or for the latter, a 
chemiluminescent camera that can capture light over a period of time from a light-emitting 
reaction to create a digital image. Images can then be quantified using computer software 
based on peak area or height of the antigen-antibody complex. 
Unfortunately, there are a number of potential problems with the repeatability, accuracy and 
time taken to complete this method due to the nature of having to complete multiple steps as 
well as loading an equal amount of total protein in each well. As well as loading equal amounts 
of each sample into the gels, it is common practice to normalise the protein of interest relative 
to reference protein such as GAPDH and β-actin or total amount of protein. Even using this 
method, co-efficient of variation for western blotting can be between 30-50% depending on 
whether a high-abundance reference protein is used, or a total protein stain is used to 
normalise the data (Aldridge et al., 2008). Producing accurate data for a large number of 
samples is therefore extremely difficult and there is a large body of evidence supported by the 
Office of Research Integrity (ORI) in the United States that laboratories have been publishing 
fraudulent and digitally manipulated western blots for a number of years, even producing 
guidelines set to expose and ensure against such misleading data (Newman, 2013). 
Alternative technologies are becoming more prevalent within biochemistry to measure an 
individual proteins abundance and modification such as enzyme-linked immunosorbent assay 
(ELISA), but are significantly more expensive and are not able to be stripped and re-probed 
like Western Blotting. Despite this ELISA’s have the advantage of analysing more samples at 
once (usually within a 96-well plate). Additionally, immunoassay array kits are becoming more 
prevalent to perform multiplex assessments of individual proteins abundance and 
modifications but the range of molecular targets available in this format are less diverse and 
less accurate in comparison to antibodies available for western blotting and 
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immunohistochemistry. Currently, commercially available kits are limited to cardiac, endocrine 
and cerebral disease assessment and have not yet been developed specifically for exercise 
biochemistry use. 
There is also a growing interest in the application of mass spectrometry in exercise and muscle 
biochemistry which gives the advantage of being able to assess multiple individual protein 
isoforms with a high degree of sensitivity over a wide dynamic range, 0.5-500ng/µl, (Bass et 
al., 2017). Using novel deuterium labelling, synthesis rates, abundance and degradation rates 
of specific proteins can also be calculated over time in response to an exercise stimulus (Brook 
et al., 2015; Brook et al., 2017; Camera et al., 2017; Hesketh et al., 2016; Srisawat et al., 
2017). 
However, this analysis can be expensive and requires a relatively high level of training and 
technical equipment that have not yet become common place within exercise/muscle 
biochemistry labs. 
 
Immunohistochemistry and immunocytochemistry 
As well as being able to quantify the abundance of an individual protein and post-translational 
modification of the protein using western blotting, it is important to understand that these 
values are representative of a homogenate which may contain multiple cell types. To properly 
understand adaptive mechanisms to exercise, immunohistochemistry can be employed to 
identify where in the muscle a protein is abundant, where the post-translational modifications 
are occurring within the cells and whether these proteins are co-localised with each other, 
indicating the transduction of a biochemical signal within a cell (protein-protein interaction), for 
example the relationship between mTOR, TSC-2 and the late endosomal/ lysosomal system 
(Jacobs et al., 2013, Song et al., 2017). 
The identification of protein targets is much like that found in western blotting, using a 
sequence of primary antibodies bound to the antigen of interest and the addition of a 
secondary antibody with a fluorophore molecule conjugated for identification. There is also an 
ever-growing catalogue of commercially available antibodies, reactive with a number of 
species. However, instead of being performed on extracted protein from a homogenate, the 
analysis is performed on thin cross-sections of tissue, either frozen and cut using a cryostat 
or fixed and then prepared by the replacement of water with paraffin-wax so that they can be 
sectioned at room temperature using a microtome. These cross-sections of tissue are normally 
collected onto glass slides (immunohistochemistry) and stained prior to being imaged using 
fluorescent microscopy, but this process can also be completed with well-plates containing 
cells. 
Current issues in immunohistochemistry relate to the accuracy and consistency of antibodies 
concentrations used as well as the potential for non-specific binding to proteins not of interest. 
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This is especially an issue when completing analysis of immunofluorescent images based on 
the intensity of a signal, all of which can be affected by photobleaching of conjugated 
fluorophore molecules and the use of the same settings during image acquisition and software 
analysis. Other studies relying on the counting of certain molecules and their locality to other 
molecules of interest are also prone to human error, an example of which is discussed 
comprehensively in regard to the counting of myonuclei in chapter 5 of this thesis. 
 
Flow Cytometry 
In cell and molecular biology, flow cytometry is a popular, objective method of analysing 
heterogenous mixtures of cells in solution to quickly profile them based on light scattering and 
fluorescent emissions of their intracellular and extracellular components (Adan et al., 2017). 
An example of this can be observed in chapter 4, table 6. 
 This biotechnological tool is used most commonly in blood immunophenotyping for cancers 
and immune-supressing diseases (over/under expression of cluster of differentiation (CD) 
markers but can also be used to analyse the cell cycle, detect cytokines and extra/intra-cellular 
protein expression. 
Briefly, a flow cytometer is made up of a fluidics system which is responsible for channelling 
liquid containing cells/particles to a focused light source. This fluidics system comprises of two 
streams that meet in a central pressurised flow chamber, 1. the sheath fluid stream (usually 
PBS) which acts as a diluent and 2. a sample stream which is injected into the flow chamber 
by a pressurised airline. The joining of these two streams within the central flow chamber 
produces a coaxial flow based on the pressure differences between the injected sheath fluid 
stream and sample stream. To ensure light scattering and fluorescent emissions are 
representative of one cell, the sample stream pressure is always greater than the sheath fluid 
stream pressure creating a single cell alignment through the optical system known as 
hydrodynamic focusing. The rate at which cells are injected into the stream can be 
manipulated depending on the nature of the experiment. For example, immunophenotyping of 
blood cell types can be completed at a high flow rate, whereas analysis of DNA content and 
lowly expressed proteins would be better completed at a slow flow rate for higher resolution 
and accuracy. The optical system is used to channel excited light from a laser to the 
cell/particle and the subsequent light scatter or fluorescent light of the particle is measured 
with a collection optic made up of optical mirrors and filters to separate and direct specific 
wavelengths to their appropriate detectors. The light signals received through these filters are 
then converted into voltages by photodetectors and are amplified into voltage pulses which 
are converted from an analogue signal into digital data (Adan et al., 2017). 
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Light scattering is produced by photons of light hitting the particle/cell and the resultant 
recorded light scattering produced is directly related to the structure and morphology of the 
cell, which can be further broken down into forward scatter (FSC) and side scatter (SSC).  
FSC light is representative of the diffraction of light collected at the same angle at which the 
light path was formed, therefore is indicative of cell-surface area/size. SSC is a measure of 
the amount of reflected and refracted light that hits the cell and is therefore used as an indicator 
of the cells granularity and internal complexity. Additionally, collected fluorescence emissions 
can be quantified to give a measure of the amount of fluorescent probe bound to an 
intracellular or extracellular protein, and therefore the abundance of that protein available for 
binding of the primary antibody (Adan et al., 2017).  
The terms flow cytometry and FACS (fluorescence activated cell sorting) are often used 
interchangeably, but, the latter is a further process. Whilst flow cytometry alone can be used 
to identify specific characteristics of a cell whether it be size, granularity, intra/extra-cellular 
signalling proteins, cytokines, or miRNAs (non-coding RNA’s that regulate post-transcriptional 
regulation of gene expression). FACS takes the principles of flow cytometry and based on light 
scatter and fluorescence parameters set by the researcher, a heterogenous population of cells 
can then be individually sorted into two or more containers; often used to produce pure 
populations of primary cells for culturing (e.g. removal of fibroblasts from a primary myoblast 
culture isolated from a muscle biopsy). Similarly, MACS (Magentic activated cell sorting) can 
be used to sort heterogenous populations of cells into different cell types using a primary 
antibody against a unique cell-surface antigen which is then conjugated to a magnetic nano-
particle, thus allowing a specific cell type to become attached to a column with a strong 
magnetic field. Cells can either be separated using a) positive selection-using nano-particles 
conjugated with antibodies to the antigen of interest whilst cells not expressing a specific-cell 
surface marker pass through or b) negative selection whereby nano-particles are selected for 
against a cell surface marker that is not of interest; therefore, allowing the cells of interest to 
pass straight through a column without being magnetically attracted (Adams et al., 2008). 
Ultimately, both methods of FACS and MACS allow for separation and purification of 
heterogenous populations of cells into a purified population of interest, which has greatly 
benefited advancements in disease and cancer diagnostics/treatment.  
Whilst these techniques have traditionally been used for individual cells and small molecules, 
there is potential to adapt these processes for use with tissue derived in-vivo (Jackaman et 
al., 2007), which will be explored in chapters 3 and 4. In brief, we propose that whole skeletal 
muscle fibers can be dispersed to produce a single muscle fibre fragment suspension suitable 
for flow cytometry applications. Whole skeletal muscle and muscle biopsies could then be 
dispersed and up to 14 fluorophores/molecular probes analysed simultaneously (Wilkerson, 
2012) through simple gating processes of fluorophores. This tool holds promise for developing 
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a better understanding of the signalling processes in relation to hypertrophy/atrophy and 
multiple diseases in a time-efficient, quantitative manner in comparison to western blotting and 
immunohistochemistry. Using FACS systems we could also separate whole muscle fibers 
dependent on their myosin isoform composition to complete further biochemical analysis 
which would be specific to that fibre type. 
 
Chapter 3: Study 1: Optimisation of whole murine skeletal muscle fiber dispersion for 
use in flow cytometry. 
 
Introduction: 
As highlighted in previous chapters, human skeletal muscle is highly complex, comprising of 
three myosin heavy chain (MHC) isoforms; MHC-I, MHC-IIa and MHC-IIx all of which have 
different capacities of maximal shortening velocity, force production per cross-sectional area 
of an individual muscle fiber, as well as differing resistance to fatigue. In rodents there are four 
MHC’s expressed, MHC-I, MHC-IIa, MHC-IId, and MHC-IIb. There are also the phenomena of 
hybrid fibers which contain at least two myosin isoforms and can be seen during maturation 
and regeneration. For example, in rodents the tibialis anterior (TA), extensor digitorum longus 
(EDL) serve to dorsiflex the ankle so therefore contains predominantly fast twitch muscle 
fibers, whereas the soleus (Sol) has a primary role to maintain stance and in slow walking so 
therefore contains predominately slow twitch muscle fibers capable of lower force production 
but with higher resistance to fatigue (Kandarian et al., 1992). 
Currently, proteomics research in the field of skeletal muscle growth and adaptation is 
performed on samples of muscle that are homogenised therefore combining a mixture of MHC 
isoforms and other cell types (including fibroblasts, satellite cells, nervous and connective 
tissues). The phosphorylation of proteins and expression of genes is then presumed to be 
representative of the whole muscle, despite the homogenate containing multiple non-muscle 
cell types and multiple muscle fiber isoforms. Whilst multiple analyses can be performed on 
these homogenised samples and this can give good indication of the mechanisms responding 
to certain stimulus within the muscle, we believe further consideration should be made to 
assess isoform specific changes due to their varying ability to hypertrophy and susceptibility 
to atrophy, each of which should be investigated independently of each other. This is 
especially important considering recent work that has displayed large variance in the rate of 
atrophy dependant on the muscle and on the muscle fiber type with satellite cells and cross-
sectional area being lost at a faster rate in MHC-II isoforms and predominately fast twitch 
muscles (Kramer et al., 2017). Other recent research has illustrated that different myosin 
heavy chain isoforms release different micro RNA’s when damaged following crush injury 
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suggesting that adaptation and remodelling follows different processes in the two (Siracusa et 
al., 2018). Investigating adaptations and responses to exercise, nutrition and pharmaceuticals 
could clearly therefore have a specific effect on one myosin isoform, but may have minimal 
effects on another myosin isoform, due to altered signalling pathways present in the 
remodelling and should be considered when designing an intervention.  
Whilst staining of multiple antigens of interest (up to 22 channels) via flow cytometry is 
common practice in assessing single cell populations, this highly accurate technique has only 
briefly been explored to assess whole tissues rather than single cells and bodily fluids. 
Jackaman et al., (2007) reported a method whereby individual proteins (skeletal 
muscle/cardiac actin, tropomyosin, dystrophin and myosin isoforms could be detected from 
fresh, whole skeletal muscle and cardiac tissues in mice via flow cytometry. Briefly, fresh 
skeletal muscle and cardiac tissue were added to a collagenase/dispase mixture and gently 
triturated in order to separate the whole muscle tissue into a solution of pieces from single 
fibres, which was later fixed and immunofluorescent stained before being ran through a flow 
cytometer. This method is suggested to be less labour-intensive than western blotting and 
immunohistochemistry and due to the protein targets, is highly applicable to diagnosing 
pathologies and assessing potential therapies not only in muscle, but in a variety of soft 
tissues. This technique also has massive potential for analysis of tissue taken in-vivo with 
laboratories now using flow cytometry to accurately measure up to 16 biomarkers from one 
single sample using a sophisticated combination of fluorescent tags, microsphere beads and 
fluorescent gating systems (Vignali, 2000).  
Therefore, we aim to replicate this method using frozen tissue to produce a novel, quantitative 
method whereby we can assess myosin heavy chain isoforms and potentially muscle fiber 
morphology based on FSC and SSC in three different skeletal muscles. The hypothesis to be 
challenged was that we would observe 1. Destruction of connective tissue via collagenase 
treatment, therefore dispersing skeletal muscle cross-sections into a single fiber solution, 2. A 
higher MHC fast fluorescent intensity for fibre fragment preparations from TA and EDL than 
the soleus, 3. A higher MHC slow fluorescent intensity for the soleus in comparison to the TA 
and EDL muscles. 
 
Methods (Single Cell Solution Optimisation of Murine Skeletal Muscle for use in Flow 
Cytometry: 
Muscle preparation   
30μm thick muscle cross-sections were cut using an OTF5000 Cryostat (Bright Instruments, 
UK) from the TA belonging to a Wistar Rat control limb, belonging to a previous study (Schmoll 
et al., 2017) using an OTF5000 Cryostat (Bright Instruments, UK). Muscle cross-sections were 
collected into frozen 12 well plates (3-5 per well) and stored in a -80oC freezer before use in 
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optimisation of fiber dispersion with collagenase and for study 2 of this chapter. The section 
thickness was chosen so that fibre pieces would be similar in length and diameter, assuming 
transverse sectioning. 
 
Collagenase I treatment 
To identify an optimal protocol to create a single cell suspension from the frozen cross 
sections, they were each treated with different concentrations of Collagenase I/HBSS (mg/ml) 
(Thermo Fisher Scientific Inc, Waltham, USA) 1ml of 1mg/ml, 0.5mg/ml, 0.25mg/ml, 
0.125mg/ml, 0.0625mg/ml and 0.03125mg/ml for an hour, being imaged at 5, 10, 20, 30, 45, 
60 minutes with gentle trituration with a 100μl pipette based on methods adapted from 
Jackaman et al., (2007) to aid in dispersion of single fiber units. This was completed at 24 oC 
within a controlled live imaging environment (Leica DMB 6000; equipped with PeCon 
incubation). 
 
Imaging and analysis 
Prior to being imaged DAPI (Vectashield® Antifade Mounting Medium with DAPI (1.5µg/ml), 
Burlinghame, CA, USA) was added to the solution to identify whether collagenase was 
disrupting myonuclei within the single cell fragment or causing destruction of nuclei. 
Microscopic images were obtained at a x10 magnification from three random points within 
each well using the controlled live imaging environment (Leica DMB 6000; equipped with 
PeCon incubation). For each image, % single cell dispersion was determined by the total 
number of myofibers present as a single unit and not attached to any other fibers to the total 
number of myofibers using Image J (IBIDI, Munich, Germany). 
 
Statistics: 
Statistical software (IBM SPSS Statistics 23; Armonk, NY: IBM Corp) was used to perform all 
statistical analyses. To assess reproducibility of our method to disperse fibers and batch-to-
batch effectiveness of the Collagenase I enzyme, we produced co-efficient of variation (COV) 
values also known as relative standard deviation (RSD), by dividing the standard deviation of 
mean % of single fiber units vs. attached fibers, by the mean % of single fiber units vs. attached 
fibers for each enzyme concentration and measurement time point. A lower COV/RSD value 
would indicate better repeatability of the single fiber dispersion.  
𝐶𝑜 − 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝑉𝑎𝑟𝑖𝑎𝑡𝑖𝑜𝑛 =
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝐷𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 
𝑀𝑒𝑎𝑛
 
Two way within-subjects ANOVA’s were also completed where enzyme concentration, time of 
incubation with Collagenase I enzyme and the interaction effects were explored.  
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Results: 
There was a significant main effect for enzyme concentration (F6,12= 833.16, P=0.0001) as 
well as a significant main effect for time (F6,12= 593.67, P=0.0001) on percentage single fiber 
dispersion. There was a significant interaction effect for time and enzyme concentration (F36,72 
= 42.97, P=0.0001) on percentage single fiber dispersion. 
There was a significantly greater mean percentage single fiber dispersion using a 1mg/ml 
(91.89 ± 4.05) concentration in comparison to 0.0625mg/ml (65.29 ± 4.2), 0.03125 (36.11 ± 
6.66), and the HBSS control (14.13 ± 1.16) after 60 minutes, (P<0.05). There were no 
significant differences between mean percentage single fiber dispersion at 60 minutes 
between 1mg/ml, 0.5mg/ml (88.99 ± 3.04, 0.25mg/ml (83.89 ± 3.52) and 0.125 mg/ml (88.02 
± 3.55), (P > 0.05). However, after 45 minutes of treatment with 1mg/ml and 0.5mg/ml 
concentrations, and 60 minutes with a 0.125mg/ml concentration fibers began to fragment and 
nuclei destroyed (Figure 2D), therefore making them unsuitable for staining. Therefore, fiber 
pieces were optimally dispersed (highest percentage of single fiber units vs attached fibres-
without degradation/fragmentation), after 60 minutes without any sign of degradation, using 
0.125mg/ml concentration of Collagenase I at 24 °C. 
 
The mean COV value for all Collagenase I enzyme concentrations, used across all time points 
measured was 7.2%, and the mean COV value for 0.125mg/ml Collagenase I was 5.47%, 
illustrating the reproducibility of the treatment on muscle cross-sections. Whilst data presented 
here illustrates single fiber dispersion using TA cross-sections, preliminary experiments 
displayed that EDL and soleus skeletal muscle cross-sections were effectively dispersed into 
single fibers despite differences in connective tissue between the different muscles (results 
not shown). 
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Figure 1: Effectiveness of Collagenase I concentrations on single muscle fiber dispersion of 
TA skeletal muscle at 24°C. Mean ± SD. 
 
 
Table 1: Co-efficient of Variation (%) for the % total number of myofibers present as a single 
unit and not attached to any other fibers to the total number of attached myofibers. 
Time 1 (mg/ml) 
0.5 
(mg/ml) 
0.25 
(mg/ml) 
0.125 
(mg/ml) 
0.0625 
(mg/ml) 
0.03125 
(mg/ml) 
HBSS 
Control  
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
5 8.4 11.0 15.2 11.0 13.0 30.4 0.0 
10 4.5 8.6 6.3 8.1 9.1 22.6 13.6 
20 2.2 6.8 6.0 8.4 16.8 10.2 4.9 
30 3.9 3.3 1.3 5.7 4.5 9.7 19.2 
45 5.1 8.6 2.1 1.8 2.5 5.5 20.1 
60 3.6 2.8 3.4 3.3 5.3 15.1 6.7 
Mean Co-Efficient of Variation: 7.2 ± 6.6% 
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A B 
C 
D 
Figure 2: A= Phase contrast of image Cross section at 0 minutes of 0.125mg/ml Collagenase 
I treatment at 22°C. B= Phase contrast/DAPI overlay of cross section dispersion after 15 
minutes of 0.125mg/ml Collagenase I treatment at 22°C. C= Phase contrast/DAPI overlay of 
single fiber fragments after 30 minutes of 0.125mg/ml Collagenase I treatment at 22°C. D= 
Phase contrast image of destruction of single fiber units after 30 minutes of 1mg/ml 
Collagenase I treatment at 24°C. 
21 
 
 
 
Figure 3: Example of optimally dispersed single muscle fiber units after 30 minutes of 
0.125mg/ml at 24°C of Collagenase I vs empty well containing Collagenase I. 
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Conclusion: 
We have demonstrated that whole skeletal muscle cross-sections can be dispersed into a 
single fiber solutions without degradation of fibers using 0.125mg/ml of Collagenase I between 
after 60 minutes at 24°C. This method is reproduceable, indicated by the COV mean of 7.6% 
between lot-to-lot experiments for differing concentrations of Collagenase I across all time-
points measured. 
 
Chapter 3: Study 2: Assessment of fiber size and type via flow cytometry using whole 
murine skeletal muscles. 
 
Methods: 
Single fiber dispersion 
As outlined in study 1, 30µm TA, EDL and soleus muscle cross-sections from a control Wistar 
rat (Schmoll et al., 2017) were cut (in series) and placed into a frozen 12-well plate (3-5 per 
well) and treated with 0.125mg/ml Collagenase I for 45-60 minutes at 24°C. 1ml of 2% 
paraformaldehyde was added per well to fix the fiber pieces for 1 hour in the dark before 
solutions were transferred to an Eppendorf. 
 
Muscle Fiber Typing 
Single Cell Solution 
A method used to prepare cultured C2C12 cells for flow cytometry was modified for the fibre 
fragment solutions. Single fiber solutions were spun at 1200rpm for 5 minutes and 
paraformaldehyde removed.  
Fragments were washed for 5 minutes x3 in HBSS before being incubated for 20 minutes in 
horse serum. Serum was washed off for 5 minutes in HBSS and primary antibodies for MYHC 
Slow (1in10 PBS), MYHC Fast (1in100 PBS) for 1 hour. The primary antibodies were washed 
off for 5 minutes x3 in HBSS and secondary antibody added (Biotinylated Horse Anti-Mouse 
IgG Antibody, rat adsorbed, Vector Laboratories Inc., Burlinghame, CA, USA) for 30 minutes. 
The secondary antibody was washed off for 5 minutes x3 in HBSS before the fluorescent tag 
(Fluorescein Avidin D, Vector Laboratories Inc., Burlinghame, CA, USA) was added in the dark 
and incubated for 30 minutes. A further wash was performed for 5 minutes x2 in HBSS before 
fiber fragments were broken from the pellet back into solution for use in the flow cytometer. 
Single fiber solutions were stained individually for each MHC isoform.  
Untreated controls were also used for each individual sample as all cells emit some levels of 
natural fluorescence (autofluorescence) from molecules such as NADH, collagen and 
aromatic amino acids (350-550nm). Positive controls were produced using Vybrant™ DiO 
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Cell-Labeling Solution (Thermo Fisher Scientific Inc, Waltham, USA) which will stain all 
protein. C2C12 myoblast cells were also used with DiO labelling solution as a further control. 
 
Histology and imaging 
To confirm any results of our flow cytometry, we performed immunohistochemistry on 10µm 
cross-sections that were cut from the TA, EDL and soleus muscles and collected onto Thermo 
Scientific™ SuperFrost Plus™ Adhesion slides (Thermo Fisher Scientific Inc, Waltham, USA) 
and fixed in acetone for 10 minutes. A ring was drawn around cross-sections using a PAP 
pen. Sections were then washed for 5 minutes x3 in PBS. Sections were incubated for 20 
minutes in horse serum (the serum in which the secondary antibody was produced to block 
any non-specific binding). Serum was washed off for 5 minutes in PBS and primary antibodies 
for MYHC Slow (1in10 PBS), MYHC Fast (1in100 PBS) for 1 hour. The primary antibodies 
were washed off x2 for 5 minutes in PBS and secondary antibody added (Biotinylated Horse 
Anti-Mouse IgG Antibody, rat adsorbed, Vector Laboratories Inc., Burlinghame, CA, USA) for 
30 minutes. The secondary antibody was washed off for 5 minutes x3 in PBS before the 
fluorescent tag (Fluorescein Avidin D, Vector Laboratories Inc., Burlinghame, CA, USA) was 
added in the dark and incubated for 30 minutes. A further wash was performed for 5 minutes 
x2 before coverslips were fixed with mounting medium containing DAPI (Vectashield® 
Antifade Mounting Medium with DAPI (1.5µg/ml), Burlinghame, CA, USA). Tilescan images of 
the entire cross-sections were performed for the MHC isoform and DAPI using a (Leica DMB 
6000, Wetzlar, Germany) and fluorescent channels overlayed. 
 
Flow Cytometry: 
The samples were analysed using flow cytometry on a BD Accuri C6 flow cytometer with BD 
CFlow® Software, collecting 2000 events per sample on a medium flow rate. Gating was 
applied, labelled as P1 to remove any small debris from analysis 
(endothelial/nervous/connective tissue) SSC-A, FSC-A and FL1 values were exported to 
characterize fluorescein fluorescent intensity.  
 
Statistics: 
All statistical analyses of FSC-A, SSC-A and fluorescent intensity (FI) were performed using 
one-way between group ANOVA’s on SPSS (v.24.0; SPSS, Chicago, IL, USA). Mean 
comparisons were assessed for FSC-A and SSC-A between skeletal muscle types, untreated 
skeletal muscle controls and C2C12 cells. Mean comparisons were also made for FL1-A 
between both muscle type and MHC isoform. Results are presented as Mean ± SE. 
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Table 2: Identification fiber type percentage using immunohistochemistry. Our percentage 
of fast and slow myosin heavy chain isoforms were in line with previous findings, (Soukup 
et al., 2002; Tasić et al., 2011). 
  
Soleus Fast = 2% Soleus Slow = 98%  
 
 
EDL Fast = 91.6% EDL Slow = 8.4% 
 
 
 
TA Fast = 96.17% TA Slow = 3.83% 
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Results: 
FSC-A Group Differences 
The mean FSC-A for TA (7,616,143 ± 1,423,839) was not significantly different (P=0.982) in 
comparison to the mean EDL FSC-A (7,499,083 ± 1,559,612), the mean soleus FSC-A 
(7,839,470 ± 2,381,724, P<0.966) and the mean C2C12 FSC-A (7,361,343 ± 2,565,489 
P<0.176). The mean EDL FSC-A was also not significantly different than the soleus (P=0.948) 
and C2C12 (P=0.169) FSC-A. There was no significant difference between Soleus FSC-A and 
the C2C12 FSC-A (P=0.189), (Tables 3-5, Column 1). 
 
SSC-A Group Differences 
The mean SSC-A for TA (3,665,319 ± 123,521) was not significantly higher (P=0.184) than 
mean EDL SSC-A (3,564,136 ± 215,103) but was significantly higher (P<0.0001) than the 
mean soleus SSC-A (3,393,722 ± 412,990) and the mean C2C12 SSC-A (1,674,980 ± 
629,488). The mean EDL FSC-A was also significantly higher than the soleus (P<0.03) and 
C2C12 (P<0.0001) FSC-A. Soleus FSC-A was also significantly higher than the C2C12 FSC-
A (P<0.0001). This shows the similarity in size between TA and EDL (predominately fast 
twitch) fiber pieces, whilst the soleus fiber piece SSC-A were significantly lower, as expected 
as soleus is a predominately slow twitch muscle containing smaller fibers. The significant 
difference between all skeletal muscle fiber pieces and the C2C12 myoblast cells was also 
expected due to the size difference between an individual myoblast and a myofiber diameter, 
(Tables 3-5, Column 3). 
 
MHC Fluorescent Intensity  
There were no significant differences between the mean control TA fluorescent intensity 
(29,362 ± 5247), the mean control EDL fluorescent intensity (27,479 ± 6585, P=0.998), the 
mean control Soleus fluorescent intensity (59,686 ± 36366, P=0.970) and the mean control 
C2C12 fluorescent intensity (8649 ± 265, P=0.970). The lower C2C12 fluorescent intensity 
although not significantly different, is presumed to be from the reduced complexity of the cell 
in comparison to myofibers, therefore emitting less auto-fluorescence. 
 
TA Fast MHC isoform fluorescent intensity (1,879,072 ± 158,876) was not significantly 
different than the EDL Fast MHC isoform fluorescent intensity (1,771,734 ± 245495, P=0.893) 
or the Soleus Fast MHC isoform fluorescent intensity (3,036,381 ± 570,718, P=0.154). These 
results were unexpected due to the lack of fast MHC isoform present in the soleus muscle. 
TA Fast MHC isoform fluorescent intensity was not significantly different in comparison to the 
TA Slow MHC isoform fluorescent intensity (1,821,531 ± 300,215, P=0.943). There was no 
significant difference between the EDL Fast MHC isoform fluorescent intensity and the Soleus 
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Fast MHC isoform fluorescent intensity (P=0.12) or higher than EDL Slow MHC isoform 
fluorescent intensity (2,060,197 ± 277,557, P=0.193). Both the TA and EDL are predominately 
fast twitch muscles, approximately 95% Fast vs 5% Slow. Whilst this trend can be observed 
in these results, we would expect the difference between these isoforms to be significantly 
greater. 
 
Soleus Fast MHC isoform fluorescent intensity was not significantly different in comparison to 
the Soleus Slow MHC isoform fluorescent intensity (2,824,846 ± 247,552, P=0.791). When 
compared to our immunohistochemistry, we would expect these results to show the opposite 
trend with Soleus Slow MHC isoform fluorescent intensity being significantly higher than the 
Fast isoform as it s a predominately slow twitch muscle. 
TA Slow MHC isoform fluorescent intensity was not significantly different than the EDL Slow 
MHC isoform fluorescent intensity (P=0.765) and Soleus Slow MHC isoform fluorescent 
intensity (P=0.214). EDL Slow MHC isoform fluorescent intensity was not significantly different 
than the Soleus Slow MHC isoform fluorescent intensity (P=0.341). Both predominately fast 
twitch muscles expressed lower (although this did not reach significance) slow MHC isoform 
fluorescent intensity in comparison to the Soleus as hypothesised. See Tables 3-5, Column 2. 
 
DiO Fluorescent Intensity-Proxy Marker for protein content 
The mean TA DiO fluorescent intensity (8,061,223 ± 1,025,116) was not significantly different 
from the EDL DiO fluorescent intensity (8,518,127 ± 467,141, P=0.568) or the Soleus DiO 
fluorescent intensity (8,753,615 ± 2,263,658, P=0.388), however was significantly higher than 
the C2C12 DiO fluorescent intensity (5,582,295 ± 1,451,303, P=0.002). The EDL DiO 
fluorescent intensity was not significantly different to the Soleus DiO fluorescent intensity 
(P=0.768), but was significantly higher than the C2C12 DiO fluorescent intensity (P=0.0001). 
The Soleus DiO fluorescent intensity was also significantly higher than the C2C12 DiO 
fluorescent intensity (P=0.05). 
The mixed population of DiO stained C2C12 cells fluorescent intensity (3,487,345 ± 378,067) 
had a significantly lower fluorescent intensity in comparison to the C2C12 DiO fluorescent 
intensity (P=0.005) and a significantly higher fluorescent intensity in comparison to the C2C12 
control fluorescent intensity (8649 ±265, P=0.0001). These results illustrate the ability of flow 
cytometers to distinguish between populations of stained, unstained and mixed populations of 
fiber pieces/cells, (Table 6). 
  
 
 
 
27 
 
 
 
Table 3: TA Control, anti-SLOW, anti-Fast, DiO, Mean ± SD  
   
SSC: 3,694,711 ± 196,955 FL1-A: 29,362 ± 5247 FSC: 6,813,860 ± 260,546 
   
SSC: 3,361,792 ± 186,146 FL1-A: 1,821,531 ± 300,215 FSC: 6,616,830 ± 482,005 
   
SSC: 3,801,069 ± 206,687 FL1-A: 1,879,072 ± 158,876 FSC: 6,801,804 ± 223,572 
   
SSC: 3,803,705 ± 143,425 FL1-A: 10,232,080 ± 371367 FSC: 10,232,080 ± 371,367 
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Table 4: EDL Control, anti-SLOW, anti-Fast, DiO 
   
SSC: 3,343.601 ± 176,373 FL1-A: 27,479 ± 6585 FSC: 6,659,800 ± 458,742 
   
SSC: 3,402,125 ± 99,888 FL1-A: 2,060,197 ± 277557 FSC: 2,060,197 ± 277,557 
   
SSC: 3,890,945 ± 205,655 FL1-A: 1,771,734 ± 245,494 FSC: 1,771,734 ± 245,494 
   
SSC: 3,619,872 ± 205,815 FL1-A: 8,518,127 ± 467,141 FSC: 9,985,746 ± 319,304 
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Table 5: Soleus Control, anti-SLOW, anti-Fast, DiO 
   
SSC: 3,310,171 ± 117,333 FL1-A: 59,686 ± 36,366 FSC: 6,620,575 ± 307,811 
   
SSC: 2,863,030 ± 49,257 FL1-A: 2,824,846 ± 247,552 FSC: 5,8383,06 ± 175,794 
   
SSC: 3,524,176 ± 218,476 FL1-A: 3,036,381 ± 570,718 FSC: 3,036,381 ± 570,718 
   
SSC: 3,877,512 ± 125,433 FL1-A: 8,753,615 ± 2,263 
658 
FSC: 11,635,658 ± 
4,287,997 
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Table 6: C2C12 Control vs 100% Stained FITC vs 50% Stained FITC 
   
SSC: 1,643,572 ± 71,614 FL1-A: 8649 ± 265 FSC: 8,655,894 ± 179,258 
   
SSC: 2,123,509 ± 76,323 FL1-A: 5,582,295 ± 
1,451,303 
FSC: 8,339,611 ± 463,248 
   
SSC: 1,825,511 ± 43,017 FL1-A: 378,067 ± 23,000 FSC: 7,523,450 ± 166,201 
 
Overall Discussion 
The aim of these studies was to produce a single fiber solution of frozen skeletal muscle tissue 
suitable for flow cytometry application, for identification of MHC fast and slow isoforms in 
various skeletal muscles. The hypothesis was that we would observe 1. Destruction of 
connective tissue via collagenase treatment, therefore dispersing skeletal muscle cross-
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sections into a single fiber solution, 2. A higher MHC fast fluorescent intensity for TA and EDL 
than the soleus, 3. A higher MHC slow fluorescent intensity for the soleus in comparison to 
the TA and EDL muscles.  
In summary, we were able to successfully produce a single fiber solution from whole frozen 
skeletal muscle tissue from a TA, EDL and soleus. We found this protocol to be repeatable 
with little variation between treatments and useful on all three muscle types using 0.125mg/ml 
of Collagenase I at 24°C for 45 minutes, which gave the most amount of single fibers without 
destruction of fiber pieces. This was confirmed by phase contrast tilescan imaging of dispersed 
muscle cross-sections into single fiber units within a 12-well plate. We were also able to 
perform immunocytochemistry on these fiber pieces individually with MHC fast and slow 
isoforms, although our results didn’t match our immunohistochemistry results. 
 
Assessing fiber piece morphology using FSC-A/SSC-A  
Jackaman et al., (2007) illustrate that after dispersion of the soleus and quadricep muscles 
that the resultant single fiber solution produces a strict population of fiber pieces much like the 
FSC/SSC produced by C2C12 cells (Column 1, Table 6). However, our fiber dispersion 
produces a more varied population as observed in Column 1 of tables 3-5. We propose that 
this may be due to the structural integrity of these fiber pieces as they flow through a 
pressurised system before light scatter and fluorescence is measured. As the original paper 
utilises fresh muscle samples that has not been flash frozen and thawed, it may be that the 
structural integrity is maintained to a better extent when using fresh tissue. However, we are 
also sceptical about the original papers reporting’s, as this technique has not been used since 
in any published work as far as we are aware despite the potential benefits. We also cannot 
confirm that our single fiber pieces are passing through the fluidics system without folding over 
or as a single unit as would happen with a normal population of single cells. This may provide 
some evidence as to why FSC/SSC is so varied despite confirmation that muscle cross-
sections are appropriately dispersed within a well. Certain flow cytometers provide 
microscopic snapshots of cells as they pass through the system which may be useful in future 
analysis.  
Despite the large variation in FSC scatter, the mean FSC (a measure of granularity) did not 
differ between any of the muscle types confirming that our fiber pieces were all the same 
thickness following the sectioning of the cross-sections (30µm).  
As highlighted in the immunohistochemistry, TA and EDL are predominately fast twitch 
muscles and their fiber diameters are in general larger than slow twitch fiber diameters, like 
that found in a predominately slow twitch muscle such as the soleus (Table 2). Understanding 
this, we have produced evidence that this technique can be used to measure fiber diameter 
as mean SSC, (a measure of cell size) was significantly higher in the TA (P<0.0001) and EDL 
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(P<0.03) in comparison to the soleus muscle fiber pieces. All skeletal muscle fiber pieces also 
had a greater mean SSC in comparison to C2C12’s (P<0.0001), as would be expected when 
comparing a muscle fiber diameter to the diameter of a C2C12 cell (Mackey & Kjaer, 2017). 
Skeletal muscle MHC isoform determination via fluorescent intensity 
We hypothesised that the TA and EDL would have produce higher MHC Fast mean 
fluorescent intensities in comparison to the soleus, and the soleus would have higher MHC 
Slow mean fluorescent intensities. Whilst our immunohistochemistry results staining muscle 
cross-sections on slides were as expected, these results did not correspond to our flow 
cytometry data. MHC Fast mean fluorescent intensity was higher in the soleus muscle in 
comparison to the TA and EDL and was approaching significance (P=0.15), although we 
would expect limited fluorescence of MHC fast in the slow twitch soleus muscle. MHC Slow 
mean fluorescent intensity was also higher in the soleus in comparison to the TA (P=0.214) 
and EDL (P=0.341) as would be expected. In fact, only the EDL muscle presented MHC 
Fast/Slow mean fluorescent intensities in the correct ratio to the immunohistochemistry results 
although they were not significantly different (P=0.193) 
Whilst we previously report successful dispersion of muscle cross-sections into single fiber 
solutions, the staining of these pieces and their detection by the flow cytometer is difficult to 
explain. Despite all immunostained fiber solutions producing significantly higher levels of FL1-
A intensity in comparison to their controls (P<0.001), there is a potential of non-specific binding 
producing fluorescence that is not from the antigen of interest. Future investigations should 
look to use antibodies bound to fluorophores outside of the natural range of autofluorescence 
(>510nm). Despite fixing and blocking with serum from which the secondary antibody was 
produced in, the effectiveness of this acting on the muscle fiber pieces within an Eppendorf is 
not well understood. Also, we propose that as soleus cross-sections were undoubtedly the 
smallest muscle cross-sections used then there was less material per well in comparison to 
the TA and EDL cross sections. Therefore, concentrations of primary antibody, secondary 
antibody and fluorescent tag used with the soleus would then therefore be exposed to less 
material producing higher binding levels and therefore FL1-A intensity. Supporting this idea, 
FL1-A values for Soleus were consistently higher in both MHC Fast and Slow in comparison 
to the TA and EDL, thus providing evidence that antibody concentrations should be more 
tightly controlled in future experiments. 
 
Conclusion: 
Whilst our initial results hold some promise for the use of flow cytometry to assess whole 
murine skeletal muscle tissue proteins, the process is not as simple and straight forward as 
first indicated by Jackaman et al., (2007). The fragility and suitability of our fiber pieces to pass 
through a flow cytometer and the effectiveness of blocking and immunostaining these pieces 
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with the appropriate antigen of interest need to be further assessed. Future studies should 
consider producing more robust staining procedures of single fiber solutions isolated from 
frozen tissues in order to accurately assess skeletal muscle isoforms and proteins.  
 
Chapter 4: Nuclear Density in muscular atrophy and recovery from atrophy 
 
Introduction: 
Skeletal muscle, responsible for locomotion and with a key function in the balance of stored 
protein and carbohydrate, is the most abundant tissue in the human body and, therefore, 
maintenance and adaptation of its structure and function are key throughout the animal 
kingdom. Preservation of muscle mass and quality during disease and ageing are currently 
key areas of research as the number of people aged over 65 is predicted to rise by 19% in the 
next decade and will contribute to a 37% increase in the number of persons living with 
disabilities ascribed to musculoskeletal disease (Guzman-Castillo et al., 2017). As skeletal 
muscle cells are post-mitotic, changes in myofiber size are governed by the rate at which 
protein synthesis and breakdown occur, allowing for phenotypical remodelling of the 
abundance and expression profiles for individual muscle protein isoforms (Cobley et al., 2016). 
Clearly, through the altered expression of gene profiles and their resultant protein products 
skeletal muscle is highly malleable, without the need for cellular apoptosis or regeneration 
(Hoppeler, 2016). 
 
Resistance training (mechanical stimuli) and protein ingestion promote a positive protein 
balance, defined as a positive ratio of synthesis to degradation and subsequent hypertrophy 
of the muscle through the IGF-1/Akt and mTOR-PS6K signalling pathways (Areta et al., 2014; 
Damas et al., 2015). Conversely, a negative net protein balance is predictive of muscular 
atrophy (a reduction in myofibrillar volume), driven by the ubiquitin-proteasome pathway and 
FoxO/MuRF1 gene regulation (Fisher et al., 2017). Atrophy occurs following disuse and 
inactivity for example bed rest, casting or space flight (Phillips et al., 2014; Rudrappa et al., 
2016; Wall et al., 2015) and elevated inflammatory states/diseases such as obesity (Kalyani 
et al., 2014), cardiac disease (Strassburg et al., 2005; Von Haeling et al., 2017), muscular 
dystrophies (Rennie et al., 1982), cancer cachexia (Smith & Tisdale, 1993; Jeevanandam et 
al., 1984), sarcopenia (aging) (Thomas, 2007) and following denervation in spinal and 
peripheral nerve injuries (Gorgey & Dudley, 2007). 
 
Myofibers are long, cylindrical cells that may be many centimetres in length dependant on the 
specific muscle and species. Due to the large volume of cytoplasm within myofibers, 
homeostasis is maintained by multiple myonuclei which are dispersed along the length of the 
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sarcolemma of the myofiber (Bruusgaard et al., 2003; Teixeira et al., 2011). The traditional 
myonuclear domain theory suggests that as myofibers are multinucleated, each individual 
myonuclei governs a certain amount of cytoplasm, ensuring protein production is sufficient 
within its locality. A theoretical myonuclear domain upper limit also exists, therefore suggesting 
that for the myofiber to become larger following resistance training, additional myonuclei must 
be recruited from the muscles resident stem cell pool (satellite cells), in order to support the 
larger cytoplasmic volume. It is also well established that an increase in individual myofiber 
size is correlated with an increase in myonuclear number and incorporation of satellite cells 
into the myofiber syncytium (Allen et al., 1999; Bruusgaard et al., 2010; Schiaffino et al., 1976; 
Verdijk et al., 2007). 
 
However, in the atrophic conditions mentioned above, the traditional myonuclear domain 
theory would suggest that during atrophy, myofibers may remove myonuclei through selective 
nuclear apoptosis to maintain a constant myonuclear domain size whilst transcriptomic and 
translational demands are reduced. Despite what the traditional model suggests, selective 
apoptosis of a single nucleus within a multinucleated cell has never been recorded 
(Gundersen, 2016). Previous work has identified that in both hindlimb suspension and 
denervation rodent models, atrophy is concomitant with markers of proaptotic signalling, 
including elevated caspases, BAX, Apaf-1, and XIAP, using standard blotting and PCR 
techniques, in both predominantly slow twitch and predominantly fast twitch muscles (Alway 
et al., 2003; Ferreira et al., 2006; Siu & Alway, 2005; Siu et al., 2005). However, despite the 
clear evidence of upregulated nuclear apoptosis in ageing and atrophy, these results are 
based upon muscle homogenates and are interpreted as indicating loss of myonuclei, despite 
the large proportion of non-myonuclei present in muscle. This is a substantial assumption to 
make considering that skeletal muscle also comprises various other non-myogenic tissues 
that make up over 50% of total nuclei in skeletal muscle (Gundersen, 2016). More recently, a 
study in sarcopenic mice found that only 0.8% (of 1200 counted per mouse) of myonuclei were 
apoptotic, whereas 46% (of 17 counted per mouse) of Pax7+ satellite cells were apoptotic. 
However, these apoptotic nuclei made up less than 20% of total apoptotic nuclei across the 
muscle, with the other 80% being attributed to stromal/capillary endothelial cell apoptosis 
(Wang et al., 2014). 
 
This highlights the importance of being able to produce a valid method of specifically 
identifying myonuclei when attempting to establish whether myonuclear apoptosis does in fact 
occur during atrophy. Immuno-histochemical approaches are most commonly employed to 
identify whether myonuclei are lost during atrophy, with great disparity between methodologies 
in identifying the myonuclei themselves and the myofiber border as well as accounting for the 
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thickness of cross-sections used. This has led to varying reports of myonuclear apoptosis 
following atrophy, with (Meneses et al., 2014; Zhang et al., 2010) reporting myonuclear loss 
when measuring nuclei per unit area of cross sections with TUNEL staining, which identifies 
breaks in the DNA strand through endonuclease activity. These reports were most likely 
attributed to the identification of non-myogenic nuclei as TUNEL binds to all broken DNA 
strands regardless of the lineage of the nuclei. Other cell types and their nuclei are often found 
in close proximity to muscle fibers including endothelial, stromal or satellite cells that lie 
beneath the basal lamina of myofibers. Using more stringent guidelines and considerations as 
to where myonuclei are present (utilising an antibody against the protein dystrophin present 
in the myofiber cytoskeleton), (Bruusgaard et al., 2012, 2010) in contrast found no loss of 
myonuclei following atrophy using the definition that myonuclei lie within the geometrical 
centre of the dystrophin ring or on the dystrophin ring. Other studies employing the dystrophin 
ring staining approach have however reported loss of myonuclei following atrophy (Dupont-
Versteegden et al., 2006; Guo et al., 2012; Oishi et al., 2008; Zhu et al., 2013), albeit that their 
reports of mean myonuclei number per control fiber on 8-10µm cross-sections (2.2) are much 
higher in comparison to that of the Gundersen group (1.7), also on 8-10 µm sections, thus 
suggesting that their analysis is less stringent (Gundersen, 2016), and may incorporate 
capillary nuclei that often lie in close proximity to the dystrophin ring but are however 
distributed between myofibers. 
 
Myofibers isolated ex-vivo following denervation have also been investigated with varying 
results, dependent on the method used for isolation. Whilst loss of myonuclei following 
denervation is reported with mechanical isolation (Viguie et al., 1997) and collagenase 
treatments (Kawano et al., 2008), extraction of single fibers via alkaline maceration has 
contrastingly shown no loss of myonuclei following long-term denervation (Bruusgaard et al., 
2010; Bruusgaard et al., 2012; Wada et al., 2010), potentially due to the less harsh method of 
extraction. Additionally, Bruusgaard and Gundersen (2008), directly observed no changes in 
myonuclei number following 28 days of denervation, despite total muscle volume decreasing 
by more than 50%, using in-vivo time-lapse imaging where specific sections of an individual 
muscle fiber could be followed during hind-limb suspension. Though there is clear evidence 
supporting nuclear loss in skeletal muscle following atrophy, there is limited evidence 
supporting that this nuclear loss is actually nuclei of myofibers. 
 
Therefore, the aim of this study is to elucidate whether myonuclei are lost or gained during 
atrophy and recovery from atrophy using stringent methodologies to identify myonuclei 
outlined in (Gundersen, 2016), using samples from a previous study in rats that investigated 
transcriptomic/epigenetic regulation related to disuse atrophy using a TTX model (Fisher et 
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al., 2017). This model silences the nerve by reversibly blocking sodium channels, without 
causing nerve damage, therefore producing atrophy independent of damage/loss of motor 
units known to be an additional cause of fiber atrophy and subsequent loss of strength 
(Doherty et al., 1993; Piasecki et al., 2018). The hypothesis to be challenged was that we 
would observe 1. a significant decrease in muscle mass, anatomical cross-sectional area and 
individual fiber area in all TTX treated groups when compared to contralateral internal control 
disuse/inactivity. We also used a second model of reduction of fiber size using continuous 
activity by electrical stimulation at 20Hz to chronically overuse the muscle. 2. Despite 
significant decreases in the muscle mass, we predict that reduction in fibre size would occur 
independently of any changes in myonuclear number per fiber between TTX treated/20Hz 
electrically stimulated and the contralateral internal control limb, therefore providing evidence 
against the current textbook theory of myonuclear domain size following atrophy and recovery 
from atrophy but supporting Gundersens idea that myonuclei number is relatively stable. 
 
Methods: 
Animals:  
Ethical approval was obtained, and experimental procedures were conducted with the 
permissions within a project licence granted under the British Home Office Animals (Scientific 
Procedures) Act 1986. Male Wistar rats weighing between 350-450g were housed at 20°C 
and 45% humidity, with food and water supplied ad libitum. Animals were assigned to 6 
groups, 3 days, 7 days, 14 days, 14 days with 7 days recovery of TTX treatment, a sham 
control and a 20Hz 7-day electrical stimulation group (n=6x6). 
 
 
Figure 4: Schematic representation of the TTX muscle atrophy model and subsequent 
sampling points.  
 
Experimental groups: 
All animals were anaesthetised during implant procedures by inhalation of isoflurane, pure 
oxygen and nitrous oxide. Once anaesthetised, a subcutaneous injection of antibiotic (5mg/kg 
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Baytril®) and an intramuscular injection of Buprenorphine (0.05mg/kg Temgesic) into the right 
quadricep were administered with strict asepsis kept throughout the procedure.   
 
TTX Groups 
The common peroneal nerve (CPN), the motor nerve responsible for contraction of the tibialis 
anterior (TA) and extensor digitorum longus (EDL) was silenced for pre-set time courses 
(Figure 1, outlined above via exposure to tetrodotoxin (TTX), a sodium channel blocker to 
induce atrophy through disuse. The electrical stimulator and osmotic pump were mounted onto 
biocompatible silicone rubber with Dacron mesh attached, implanted sub-cutaneously in the 
scapula region and sutured to the abdominal wall by way of Dacron mesh that extended from 
the silicone rubber to prevent migration of the implants during free-living movement. The 
miniosmotic pump (Mini Osmotic Pump 2002; Alzet, Cupertino, CA, USA) delivered the TTX 
along a delivery tube directed to a silicone rubber cuff placed around the CPN of the left hind-
limb. The osmotic pump successfully delivered 0.5µl/h TTX (350mg/ml in sterile 0.9% saline) 
to the cuff surrounding the CPN therefore blocking ankle dorsiflexion, whilst allowing normal 
voluntary plantarflexion through the tibial nerve was maintained. The welfare and mobility of 
the rats was minimally affected during exposure. To ensure that the nerve cuff was effectively 
blocking nervous stimulation of the muscle, a miniature, implantable, electrical stimulator 
developed to deliver a fixed frequency of 20Hz which can be turned on and off remotely by a 
pre-programmed sequence of light flashes through the skin of the rat using a stroboscope 
(Jarvis & Salmons, 1991). The output electrodes were placed near to the CPN just above the 
blocking cuff (Fig. 2). No contraction of the muscle following 20Hz stimulation would indicate 
that the CPN is being appropriately blocked. For the 14-day exposure with 7-day recovery 
group, osmotic pumps were appropriately loaded therefore allowing for termination of TTX 
infusion after 14 days to allow for nerve activity to resume for 7 days of recovery via habitual 
physical activity. The right hind-limb was used as a contralateral control limb in all groups.  
 
20Hz Stimulation Group 
The 20Hz stimulation group received identical surgeries and implants to the TTX groups 
without loading of TTX into the osmotic pump. Therefore, nerve activity remained and instead 
the group received 20Hz of electrical stimulation for a period of 7 days to chronically overuse 
the muscle so that a shift to smaller fiber type occurs as previously described (Jarvis & 
Salmons, 1991; Jarvis et al., 1996). 
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Figure 5: Schematic of Nerve Cuff and Stimulator Electrodes In-Situ 
 
Morphology and Nuclear Density: 
Preparation 
After each group had finished their allocated experimental time course, animals were 
humanely euthanized with an increasing concentration of CO2 and cervical dislocation. The 
tibialis anterior was extracted, excess connective tissue removed and weighed for assessment 
of muscle mass and samples taken for transcriptional analysis which has previously been 
reported (Fisher et al., 2017). The proximal end of the muscle was frozen and fixed onto cork 
discs in OCT (Tissue-Tek® O.C.T. Compound, Sakura® Finetek, USA), using isopentane, 
pre-cooled in liquid nitrogen prior to cutting at 10μm using an OTF5000 Cryostat (Bright 
Instruments, UK) onto Thermo Scientific™ SuperFrost Plus™ Adhesion slides (Thermo Fisher 
Scientific Inc, Waltham, USA) for histological/ immunohistochemical use, to provide the 
sections analysed here. 
 
Staining and Imaging 
Fluorescein labelled Wheat Germ Agglutinin (WGA) staining was performed to identify 
changes in individual cell size and anatomical cross-sectional area (ACSA) of the muscle. 
WGA binds to membrane glycoproteins therefore staining all cell membranes, connective 
tissue and vasculature. WGA (5µl WGA (Fluorescein labeled Wheat Germ Agglutinin, Vector 
Laboratories Inc., Burlinghame, CA, USA) per 1ml PBS) was pipetted onto thawed sections 
and incubated for 1 hour in the dark. 3x5 minute rinses were performed with PBS on the slide 
before coverslips were fixed with mounting medium containing DAPI to visualize the nuclei 
(Vectashield® Antifade Mounting Medium with DAPI (1.5µg/ml), Burlinghame, CA, USA). 
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Tilescan images of the entire cross-sections were performed for WGA and DAPI using a (Leica 
DMB 6000, Wetzlar, Germany) and fluorescent channels overlayed (Figure 6A).  
 
Analysis 
All images were coded and then analysed by the primary researcher in a blinded manner using 
Image J (IBIDI, Munich, Germany) for average individual myofiber size, myofiber number, 
ACSA of the entire muscle and average number of myonuclei per myofiber, average individual 
cell size and number was performed using an automated cell counting method using Adobe 
Photoshop (Adobe Systems, San Jose, California, USA) and Image-Pro Plus 5.1 software 
(Media Cybernetics, MD, USA). Briefly, WGA only images are converted to grayscale and 
filtered to stylize edges in order to highlight cell membranes. Ranges of acceptance were 
employed to identify individual cells; (Area 500-500,000µm, minimum feret diameter 0-
500,000µm, Perimeter 0-430µm, Roundness 0-3). This counting process is illustrated in 
Figure 6. ACSA was calculated from tile-scanned images of the entire muscle cross-section 
by tracing the outline of the cross-section using Image J (IBIDI, Munich, Germany). Average 
number of myonuclei per fiber (on 10µm sections) was calculated by taking 3 random fields of 
view per muscle from the tilescanned image. Approximately 120-400 fibers per image were 
analysed depending on the state of atrophy and regional positioning of the image within the 
cross-section. Myonuclei were identified using adaptation of previously reported techniques 
(Bruusgaard et al., 2010, 2012; Gunderson, 2016). Briefly, myonuclei were defined as nuclei 
with their geometrical center located clearly inside the myofiber membrane, combined with 
both nuclei found within the borders of the myofiber and nuclei with their geometrical center 
on the membrane of the myofiber. Myonuclear domain size was calculated by dividing the 
mean individual fiber cross-sectional area by the mean myonuclei number per fiber cross-
section.  
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Figure 6A-G (Left to right): A=Tilescanned, overlap image of WGA and DAPI immunostaining 
of a left tibialis anterior 10µm section. B=Image converted to grayscale using photoshop. C-
E=Find Edges function to highlight all cell membranes, contrast/brightness enhanced followed 
by erasing the background and large tendons. F= Ranges of acceptance were employed to 
identify individual cells; (Area 500-500,000µm, minimum ferret diameter 0-500,000µm, 
Perimeter 0-430µm, Roundness 0-3) G=Magnified image of F, illustrating automated cell 
counting of myofibers and disregard for blood vessels/connective tissue. 
 
Statistical Analyses 
 
All statistical analyses of morphological and myonuclei data were performed using SPSS 
(v.24.0; SPSS, Chicago, IL, USA). Morphological (muscle mass, anatomical cross-sectional 
area, mean individual fiber area, fiber number and myonuclei per myofiber) comparisons 
between experimental and control conditions were assessed via a 1-way between-group 
ANOVA. Pearson’s correlation was also calculated to assess co-efficient values between each 
morphological data set. 
 
Results: 
Muscle Mass: (Reported previously in Fisher et al., (2017), included for context. 
Exposure to TTX produced an average of 7.06 ± 2.4% loss in TA muscle mass at 3 days, 
28.76 ± 5.1% at 7 days, and 50.7 ± 2.7% loss after 14 days that resulted in statistical 
significance at all time points vs. the contralateral internal control (P < 0.001) and a significant 
difference between paired comparisons of 3 and 7 days, 3 and 14 days, 7 and 14 days (P < 
0.001). After 14 days of TTX exposure followed by 7 days of cessation in the recovery group, 
muscle mass significantly recovered by 51.7% vs 14 days of TTX exposure (P < 0.001). Seven 
days of recovery did not completely restore muscle mass, as muscle mass was still 
significantly lower than control (P < 0.001) and total muscle mass was nearly equivalent to 
levels at 7 days of TTX administration, which suggests that rates of loss over 7 days are in 
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line with rates of recovery. We therefore report significant skeletal muscle atrophy of the TA 
muscles with disuse and significant recovery of muscle mass after 7 days of cessation of TTX 
administration and the return of normal habitual physical activity vs. 14 days of TTX induced 
inactivity of the muscle. A significant decline in muscle mass was also found for the 20Hz 
electrically stimulated group 12 ± 4.84% (P <0.002). There was no significant reduction in 
muscle mass in the sham control group (-0.133 ± 3.79%, P= 0.873). 
 
Muscle Anatomical Cross-Sectional Area: 
Exposure to TTX produced a progressive reduction in mean muscle fiber ACSA of 6.4 ± 6.2% 
at 3 days, 29.75 ± 5.1% at 7 days, and 68.11 ± 4.97% at 14 days of TTX exposure, with 7 and 
14 days of TTX being significantly reduced in comparison to the control limb (P < 0.003 and P 
< 0.001) respectively. Similarly to TA muscle mass, upon TTX cessation, the 14-day TTX + 7-
day recovery group recovered muscle ACSA significantly in comparison with 14 days of TTX 
induced atrophy alone (68.11 ± 4.97% vs. 24.47± 9.5%, P < 0.002). A significant decline in 
muscle ACSA was also found for the 20Hz electrically stimulated group, 11.47 ± 5% (P < 
0.004). There was no significant reduction in muscle ACSA in the sham control group (0.15 ± 
1.1%, P = 0.982). 
  
Individual Fiber Area Changes 
Increasing the duration of exposure to TTX also caused a cumulative reduction in mean 
individual fiber size calculated through computational, automated, cell counting by 11.65 ± 
4.21% at 3 days, 24.56 ± 7.21% at 7 days and 47.57 ± 3.12% after 14 days that resulted in 
statistical significance at all time points vs. the contralateral internal control (P <0.001) and a 
significant difference between paired comparisons of 3 and 7 days, 3 and 14 days, 7 and 14 
days (P <0.001). In the 14 days TTX exposure with 7 days recovery group, mean individual 
fiber size was reduced by 20.82 ± 4.1% (P <0.001), illustrating a recovery of fiber size by 26.75 
± 3.1% in comparison to 14 days atrophy alone (P <0.001). This decrease in average fiber 
size and shift towards smaller atrophied fibers is outlined in a continuous format in figure 12 
a-f.  
 
Fiber Number 
There was a significant percentage fiber loss after 14 days of TTX induced atrophy -9.44 ± 
5.09% (P <0.0001) and 7 days of 20Hz electrical stimulation -3.54 ± 3.04% (P <0.05) in 
comparison to the sham control using our computational, automated, cell counting technique. 
There was no loss in the 3-day group -0.26 ± 2.84% (P= 0.635), 7-day group -1.15 ± 5.06% 
(P= 0.383) and 14 days with 7 days recovery group -0.525 ± 2.77% (P= 0.558).  
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Myonuclei number per fiber cross-section 
There were no significant percentage changes in myonuclei number per myofiber when 
compared to sham control and between limbs -1.36 ± 0.0219% after 14 days, 0.1 ± 0.0143 
after 7 days, 1.34 ± 0.0164 after 3 days and -0.6667 ± 0.0113 after 14 days with 7 days 
recovery (P >0.7). There were also no significant percentage changes in the sham control 
group 1.379 ± 0.245 in comparison to the 20Hz electrical stimulation group 2.098 ± 0.215 (P 
>0.6). 
 
Myonuclear Domain Size Changes  
There was a significant reduction in myonuclear domain size following TTX administration, -
31.32 ± 6.34% after 14 days, -19.72 ± 4.98% after 7 days and -11.63 ± 2.35 after 3 days, all 
of which resulted in statistical significance at all time points vs. the contralateral internal control 
and percent change in the sham surgery group 3.79 ± 1.6 (P< 0.05). After 14 days of atrophy 
with 7 days recovery, myonuclear domain size had recovered to -17.79 ± 4.9%, an increase 
of 43.2%. A significant decline in myonuclear domain size was also found for the 20Hz 
electrical stimulation group of -3.53 ± 2.33% (P< 0.05) 
 
Correlations between percent changes in muscle weight, total muscle cross-sectional area, 
individual fiber area and myonuclear domain size changes  
There was a significant positive correlation of percentage change in total muscle mass to 
percentage changes in distal ACSA (R2=0.931, P =0.007), distal individual fiber area 
percentage changes (R2=0.977, P =0.001) and the myonuclear domain size percent changes 
(R2=0.938, P =0.006). There was a significant positive correlation between ACSA percentage 
change and distal individual fiber area percent change (R2=0.924, P =0.009) and myonuclear 
domain size percent change (R2=0.838, P =0.037). There was no correlation between 
percentage changes in myonuclei number per myofiber and percent changes in muscle weight 
(R2=-0.92, P = 0.862), muscle ACSA (R2=-0.263, P = 0.615), and individual fiber area 
(R2=0.064, P = 0.904). This illustrates there is a strong relationship between a reduction in 
muscle mass with loss of ACSA and individual fiber area as would be expected and these 
changes occur independently of myonuclear apoptosis.  
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Figure 7: Correlations of % change in muscle mass to % changes in ACSA, individual fiber 
area and myonuclear domain size (Blue dots represent group means) 
 
Figure 8: Changes in tibialis anterior (left as a percentage of right) muscle mass, anatomical 
cross-sectional area and individual mean fiber size after varying durations of TTX 
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administration, sham surgery and a 20Hz electrically stimulated control. *Significantly different 
from sham control (p= <0.05). # Significantly different from 14 days atrophy (P= <0.05)  
Figure 9: 14 Days TTX induced atrophy vs 14 days contralateral internal control in the tibialis 
anterior. Illustrates a clear loss in anatomical cross-sectional area. Scale bar = 1mm 
(1000µm). 
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Figure 10a-b: Myonuclear Domain Size Changes presented as both mean group values, left 
vs. right and as percentage changes after varying durations of TTX administration, sham 
surgery and a 20Hz electrically stimulated control. A: * Significantly different from the 
contralateral internal control. B: *Significantly different from sham control (p= <0.05).  
 
 
 
Figure 11: Comparison of mean myonuclei counts between limbs across varying time courses 
with accompanying WGA/DAPI images. 
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Figure 12a-f: Individual Cell Area (xFmin diameter x π) frequency experimental (orange) vs. control 
(grey). 
An orange shift to the left illustrates a loss in fiber size in the TTX treated limb. Mean left vs 
right individual cell area is illustrated with a line graph.  
 
Discussion: 
Summary: 
The aim of this study was to produce TTX induced atrophy in the tibialis anterior muscle of the 
left hindlimb, after varying durations of TTX treatment, to elucidate the rate at which the tibialis 
anterior muscle atrophies in response to disuse/inactivity and whether myonuclear number 
per fiber is altered as a result of a reduction in domain volume. The hypothesis to be tested 
was that we would observe 1. a significant decrease in muscle mass, ACSA and individual 
fiber area in all TTX treated groups when compared to contralateral internal controls through 
disuse/inactivity. 2. Despite significant decreases in morphology, we hypothesised that 
decreases in the mass and cross-sectional area of the muscle would occur independently of 
any changes in myonuclear number per fiber between TTX treated and the contralateral 
internal control limb. 3, The 7-day 20Hz electrical stimulation group model would also produce 
significant atrophy to the tibialis anterior via overuse, in comparison to the contralateral internal 
control limb and the loss in muscle mass, ACSA and individual fiber area would occur 
independently of changes in myonuclei number per fiber. Previous models of the myonuclear 
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domain theory have suggested that when myofibers hypertrophy, myonuclei are recruited into 
the syncytium of myofibers from satellite cells to help support the larger cytoplasmic volume. 
Following atrophy, when cytoplasmic volume decreases, excess myonuclei are removed 
through apoptosis.  
Through TTX exposure to the CPN, therefore blocking TA contraction, we demonstrated that 
we could cause considerable significant skeletal muscle atrophy in the tibialis anterior of the 
rat. The significant loss of muscle mass of 50.7 ± 2.7% (P <0.0001) after 14 days of exposure 
was concomitant with a loss in anatomical cross-sectional area 68.11 ± 4.97% (P <0.003) and 
the average cell size 47.57 ± 3.12 (P< 0.001) when compared to the contralateral internal 
control limb, as expected with the loss of sarcoplasmic volume and myofibrillar proteins 
(Wilkinson et al, 2018).  This represents changes in muscle size that are well beyond most 
exercise-related changes in human subjects. These findings displayed high correlation 
coefficients with R2 achieving a minimum of 0.93 between muscle weight, ACSA and individual 
mean fiber area.  
Using stringent immunohistochemistry technique guidelines adapted from Gundersen (2016), 
we were able to establish that myonuclear number per myofiber cross section did not change 
significantly alter across all treated muscles between treated limbs and internal control limbs 
studied and this showed no correlation across any time points with muscle mass, ACSA and 
individual fiber area. This provides evidence of the remarkable capability of skeletal muscle to 
maintain its myonuclei number despite considerable atrophy, albeit occurring over a short 
period in this study. Due to this maintenance, following subsequent recovery from atrophy, 
ACSA, individual fiber area and muscle weight all recovered substantially, occurring 
independently of any change in myonuclei number. This provides evidence that adult rodent 
skeletal muscle can hypertrophy following return to activity to its normal state, without the need 
for incorporation of satellite cells into the myofiber syncytium, as there is already a substantial 
number of myonuclei available to maintain the cytoplasmic volume.  
 
Limited evidence for hypoplasia during atrophy and hyperplasia during recovery: 
Whilst our automated cell counting data indicated that after 14 days of TTX induced atrophy 
significant fiber loss had occurred (-9.44 ± 5.09%), our histological analysis showed no 
evidence of degrading fibers. There was also no significant evidence of 
hypoplasia/hyperplasia in the 3 or 7 days of TTX administration.  Additionally, after 14 days 
with 7 days recovery, fiber number had appeared to have recovered to that of the sham control. 
However, there was no evidence of hyperplasia (centralised nuclei) in any of the histology 
sections, signifying that if hyperplasia had occurred, our time point of extraction was too late 
to observe this occurring. Instead, we believe variations in fiber number are more likely due to 
measurement error in our automated counting methodology (extremely small atrophied fibers 
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not counted in our inclusion criteria that could not be distinguished between connective tissues 
if this were the case), in addition to cross-section quality and distance cut from the 
myotendinous junction. Another consideration must be that due to the considerable atrophy, 
the shape of the muscle changed meaning that the atrophied muscles were analysed nearer 
to the end of the muscle and therefore naturally contained slightly fewer fibers. Supporting 
this, whilst it is established that ageing can cause fiber loss as a result of loss of motor units 
and denervation (Frontera et al., 2000; Lexell et al., 1988; Spendiff et al., 2016; McPhee et al., 
2018), as far as we are aware, there is no evidence of fiber loss (hypoplasia) following short 
term disuse atrophy. There is also no evidence of skeletal muscle hyperplasia occurring 
following return to normal, habitual, physical activity following hind-limb suspension, exposure 
to microgravity and TTX administration studies in rodents nor bedrest or limb immobilisation 
studies in humans. The novelty of our model also ensures that nerve damage does not occur, 
instead the nerve is simply silenced therefore preserving motor units, unlike the 
atrophy/hypoplasia occurring in sarcopenia (Fisher et al., 2017). Despite evidence suggesting 
that various forms of mechanical loading can produce a 15 ± 19.60% increase in number of 
fibers (Kelley, 1996), this is species specific (avian, 20.95%, and mammalian, 7.97% 
increases). Furthermore, previous animal work (Sola et al., 1973) has suggested that skeletal 
muscle hyperplasia occurs following mechanical stretch as a function of both the amount of 
stretch, length of chronic training and the amount of hypertrophy, with ‘de-novo’ fibers only 
being added after approximately 70% hypertrophy of the original muscle size. As neither of 
our groups had undergone extensive stretching/mechanical load or hypertrophied to the extent 
that splitting of existing fibers may occur, we believe that the likelihood of hyperplasia 
attributing to the recovery of the muscle following atrophy is unlikely to occur. We believe it 
represents increases in individual cell size and protein content, rather than increase in fiber 
number, in line with our automated cell counting results. 
 
Are removal and recruitment of myonuclei obligatory for atrophy and recovery from atrophy? 
Briefly, using our method of identification for myonuclei we observed no significant changes 
in myonuclei number after 2 weeks between atrophied muscles and control muscles or 
between any groups of TTX administration or electrical stimulation. These results suggest that 
skeletal muscle atrophy and the ensuing recovery from atrophy following disuse, is in part 
controlled by the remarkable capability of the existing nuclear population to adequately control 
substantial changes in the sarcoplasmic volume of their myonuclear domains in the short term, 
in order to support retrieval of normal, healthy muscle mass. However, we cannot confirm that 
this is the case in longer periods of atrophy. In terms of the rate at which the tibialis anterior 
atrophied, previous studies employing TTX administration to induce paralysis and subsequent 
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atrophy observed similar levels of atrophy in the tibialis anterior, confirmed by measurements 
of both loss in muscle mass and individual fiber area at both 7 days (19 ± 5%, 26 ± 14% and 
14 days (39 ± 10%, 45 ± 5%) (Gardiner et al., 1992; Salter et al., 2003). Whilst our analysis 
did not include isoform specific losses in fiber cross-sectional area, previous studies have 
shown that in the tibialis anterior, a predominantly fast twitch muscle (98%), type IIa fibers (29 
± 10% loss) appeared to atrophy less than type IIb fibers (43 ± 7% loss) after a period of 1-
week (Salter et al., 2003); potentially through an evolutionary mechanism and natural 
selection, whereby type IIb fibers atrophy quicker than their oxidative counterparts. This may 
be to help preserve more mitochondria found in type IIa fibers, and to eliminate the cost of 
having more contractile proteins and ATPase activity in the type IIb fibers (Pette & Staron, 
2001). Type II muscle fibers have also been found to undergo extensive atrophy in elderly hip 
fracture patients, to a greater extent than type I fibers in the vastus lateralis (a mixed fiber 
muscle, Staron et al., 2000) (Kramer et al., 2017). As we have established, the reduction in 
fiber size and mass following disuse happens independently of myonuclei loss, therefore 
proposing that this gives muscle a mechanism whereby following atrophy/periods of net 
protein degradation, cytoplasmic contents can be quickly removed and on the other hand, in 
periods of activity and net protein synthesis, muscle can quickly restore protein content and 
contractile units, without the need for recruiting new myonuclei into the syncytium. 
Subsequently following recovery from the TTX induced atrophy as the muscle hypertrophies, 
our results provide further evidence that adult skeletal muscle can hypertrophy (51.7% muscle 
mass, 43.6% ACSA and 26.75% individual fiber area increases after 7 days recovery), without 
the recruitment of myonuclei into the myofiber syncytium, at least when returning to ‘normal 
size’. Our results share similarities with (Jackson et al., 2012) who reported radial growth of 
cross-sectional area of up to 60% following 2 weeks of reloading via normal, habitual, physical 
activity in a hind-limb suspension model, using a satellite cell knockout mouse. 
Despite the large amount of atrophy we produced after 2 weeks of TTX administration, it is 
clear that this did not cause complete removal of fibers or apoptosis of any myonuclei unlike 
that found in disease states such as sarcopenia following denervation (Cheema et al., 2015) 
and damage to the sarcolemma following contraction in muscular dystrophies (Campbell, 
1995). Thus we are suggesting that only when muscle cannot adapt to the environment 
through control of the phenotype, in the case of chronic loading (Kadi et al., 2000; 2005) and 
extreme damage (Murphy et al., 2011), then the muscles resident stem cells, the satellite cell 
will become activated and fuse with current myofibers to aid in growth, or satellite cells will 
fuse together to produce ‘de-novo’ fibers in extreme inflammatory or overload circumstances 
(You et al., 2018). Although satellite cell activation was not measured in this study, one would 
expect a subsequent increase in myonuclei number per fibre cross-section if satellite cells 
were in fact activating, proliferating and fusing to myofibers during the recovery from atrophy. 
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Further evidence supporting this theory has shown that following overload-induced growth 
(synergist ablation), hypertrophic adaptation continues in the absence of satellite cells in fully 
grown Pax7- DTA adult mice but is severely blunted or stopped completely in neonatal Pax7- 
DTA mouse growth, where the mean myonuclei per fiber is lower and therefore cannot grow 
to the same extent without new myonuclei (Murach et al., 2017). Whilst some studies show 
activation and proliferation of satellite cells during hypertrophy without integration into existing 
fibers, this may be more related to the remodelling of the extracellular matrix and controlling 
fibroblasts if the cytoplasmic volume is controllable by the myonuclear density (Murphy et al., 
2011). 
This provides evidence supporting the hypothesis that there may be a ceiling effect whereby 
there is a limit to which a myonuclei can control a given amount of cytoplasm and therefore a 
limit to cell hypertrophy, after which there is signalling cascade to trigger recruitment of satellite 
cells into myofiber if satellite cells are not present, as is the case in Pax7-DTA mice, growth 
will not occur (Murphy et al., 2011). (Kadi et al., 2005; Petrella et al., 2006, 2008) has 
previously reported that the limit to hypertrophy without triggering recruitment of myonuclei is 
between 17-36%. Whilst these reports have often been made in regard to the limit following 
strength training, the muscle in fact has the potential to hypertrophy more than what has 
previously been indicated without the aid of satellite cells, if the muscle is atrophied and 
possesses a low myonuclear domain size. This contributes to the theory proposed by 
Gundersen (2016), that muscle has a cellular memory of training history, through maintaining 
any myonuclear accretion even during periods of atrophy. To test this further (Bruusgaard et 
al., (2010) and Egner et al., (2013) have previously produced hypertrophy and myonuclear 
accretion in a mouse model, via a 2-week pre-treatment with testosterone. This hormone 
drives an increase in protein synthesis through IGF-1 and downstream mTOR/p70s6k 
signalling (Basualto-Alarcón et al., 2013) and satellite cell activation/fusion to myofibers 
(Joubert & Tobin, 1995; Sinha-Hikim et al., 2003). After 3 weeks of withdrawal of testosterone, 
myofiber size had returned to normal but myonuclei number was still elevated. When this 
group was subjected to overload, those with pre-treatment of testosterone grew by 36% in 2-
weeks in comparison to only 6% in the sham control, again demonstrating the extraordinary 
ability of myonuclei to act as a protective mechanism when muscle must quickly adapt. Whilst 
this is a supraphysiological approach to promote fiber enlargement alongside incorporation of 
satellite cells within the muscle, further investigations must be made using resistance 
training/nutritional intervention to elucidate whether the same occurs as in the above 
testosterone study; similarly to the design used in the epigenetic study of muscle hypertrophy, 
Seaborne et al., (2018).  
Whilst epigenetic alterations have been shown to aid in hypertrophy Seaborne et al., (2018), 
our study amongst others has provided evidence of a myonuclear memory through the 
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maintenance of myonuclear number per fiber cross-section during atrophy and recovery from 
atrophy. Though atrophy leads to small fibers with a high nuclear density and a small 
myonuclear domain, the muscle is able to recover without recruitment of new myonuclei 
allowing for an efficient growth period until myonuclear density becomes incapable of 
maintaining the cytoplasmic volume. 
 
Limitations: 
Whilst our analysis followed stringent guidelines and methodologies outlined previously by 
Gundersen (2016) and adapted further still, there are still clear potential discrepancies 
between techniques for identifying and counting myonuclei in histology/immunohistochemical 
cross sections which has probably contributed to differences reported in myonuclei number at 
both an intra and inter species level. Whilst we are confident that our method removes the 
counting of non-myonuclei in surrounding connective tissues and capillaries we cannot rule 
out the possible false reporting of satellite cells in our myonuclei count and other non-
myonuclei. However, the range of myonuclei per fiber cross-section in our analysis ranged 
from 1.43-1.51 which is lower than that reported in other immunohistochemical atrophy studies 
using a dystrophin ring technique (1.7-3.15) (Gundersen, 2016), suggesting that our inclusion 
criteria for myonuclei was more rigorous or that our cross-sections were slightly thinner. Since 
the original analysis in this study, a study from the Gundersen group has identified and 
validated the use of the antibody against Pericentriolar material 1 (PCM1) to identify nuclei 
specific to myogenic lineage without binding to satellite cell, allowing us to elucidate basic 
biological processes involved in myonuclear domain size changes in response to atrophy and 
hypertrophy (Brunn, 2018; Murach et al., 2018; Winje et al., 2018). The gene itself encoding 
the PCM1 228-kD centrosome protein is responsible for cytoskeleton organisation, nucleation 
and anchoring of microtubules and has also been shown to be pivotal for the subsarcolemmal 
positioning of myonuclei in myofibers (Espigat-Georger et al., 2016; Gimpel et al., 2017). The 
marker itself is confined to the nuclear membrane of all cells in interphase of the cell cycle, 
irrespective of cell lineage. As myonuclei do not undergo mitosis and myogenesis is controlled 
by satellite cells within skeletal muscle, this marker provides a useful discrimination between 
myonuclei and non-myonuclei, and therefore, should become standard practice in any skeletal 
muscle research relating to the myonuclear domain. 
 
Conclusion: 
Whilst the original work from our group (Fisher et al. 2017) has provided evidence that skeletal 
muscle disuse atrophy is associated with reversible epigenetic alterations of the 
transcriptome, allowing for recovery of gene expression in recovery from atrophy back to the 
muscles original state, regarded as an ‘epi-memory’ (Seaborne et al., 2018; Sharples et al., 
54 
 
2016), work from the Gundersen group and from this study clearly illustrate the potential for 
skeletal muscle to also possess a cellular memory of its original size and training history prior 
to atrophying, due to the durability of myonuclei. This would suggest that further therapeutic 
research should not be concentrated on recruitment of satellite cells into the syncytium, nor 
blocking of apoptotic pathways, but instead should concentrate on the promotion of protein 
synthesis and reduction of protein degradation within the muscle. We cannot however rule out 
that myonuclei apoptosis does not occur after longer periods of disuse atrophy. We therefore 
propose to further test this hypothesis by adding additional groups to this study to observe 
atrophy over a longer time course. Additionally, using our co-activation model of electrical 
stimulation (Schmoll et al., 2017), we propose to chronically train Wistar rats, to stimulate 
hypertrophy and remodelling of the myofiber to stimulate incorporation of satellite cells into 
the myofiber to increase the myonuclei number per fiber. Following this, we would produce 
atrophy within different groups to establish the time course relationship between trained and 
untrained muscle atrophy and recovery following atrophy, as well as any potential changes in 
myonuclei number using the most valid methods of identification (anti-PCM1/dystrophin ring 
labelling). 
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Chapter 5: Future Directions for PhD study 
 
Adequate muscle strength is a major factor in maintaining mobility and independent living, and 
thus a key focus of research in healthy ageing across the globe. Allied Health professionals 
have a key role in enhancing the quality of life in older years, but they need effective means 
to enhance muscle strength and endurance. Resistance training exercise generates 
mechanical stimuli within muscles that trigger adaptive cellular responses. Typically, muscle 
fibres grow by hypertrophy (an accumulation of myofibrillar proteins that increases muscle 
cross sectional area and strength). The cellular level responses lead to larger total skeletal 
muscle mass and quality which contributes significantly to prevention of morbidity and is 
associated with higher quality of life in the elderly. The adaptation and regeneration of skeletal 
muscle involves the activation of satellite cells (the resident muscle stem cell), and the 
mechanistic target of rapamycin (mTOR) signaling pathway, which centrally regulates 
mammalian cell growth, metabolism and survival. We know that mechanical signaling 
significantly activates mTOR pathways and that mTOR activation alone can induce 
hypertrophy. But our knowledge of how these mechanical stimuli are converted into 
biochemical events that induce cell growth and hypertrophy is extremely limited.  
Recently, several respected scientists have published papers investigating the intracellular 
movement and co-localisation of mTOR with other signaling proteins, such as lysosomal 
proteins and tuberous sclerosis complex 2 (TSC2) following mechanical stimuli. Once these 
mechanisms are better understood, there may be opportunities to enhance the hypertrophic 
response and to reduce the atrophic response by identifying targets that are protective of 
muscle mass and degeneration. (Jacobs et al., 2013, Song et al., 2017). 
Although this research is highly respected, there are key limitations that we can overcome with 
new techniques included in this thesis and from previous work from within the research group 
(Fisher et al., 2017; Schmoll et al., 2017). Studies in competing laboratories tend to use just 
one bout of muscle activation under anesthesia to investigate translocation of mTOR and 
protein complex localisation following mechanical stimuli. This is also only assessed at the 
mid-belly level of one muscle. To translate this work to a stage at which it is applicable to the 
complexity of mammalian musculature that undergoes many mechanical stimuli per day, we 
will use a novel, surgically implanted, programmable electrical stimulator in our rodent model 
to produce mechanical stimuli in the lower limb with control over intensity, duration per day 
and length in days or weeks of the prescribed exercise regime. Moreover, we can limit 
programmed exercise to one limb, so that the contralateral limb serves as an essential control. 
We have established a programme of well-tolerated resisted exercise by co-contraction (one 
set of muscles working against another) that can generate consistent hypertrophy of about 
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15% with two 20-minute programmed sessions per day. We will investigate the time course of 
the response and underlying mechanisms of adaptation, harvesting muscles at 2 days, 7 days 
and 28 days of exercise, and investigate the markers of over-stimulation by increasing the 
numbers of sessions per day from 2 to 6. 
Through immunofluorescence, confocal microscopy and flow cytometry techniques developed 
in this thesis, we will measure regional changes and muscle group differences, to pinpoint 
where mechanical stimuli are regulating mTOR signaling and why some muscle groups are 
deficient in mTOR related signaling proteins and are therefore susceptible to atrophy (loss of 
muscle mass/degeneration). With methods developed during this year of my study, we can 
now complete morphological analysis of whole muscle cross-sections of the proximal, mid-
belly and distal parts of the muscle with computational image analysis. We can thus investigate 
regional differences in mTOR translocation and protein complex co-localisation, as well as 
changes in morphology, myonuclei number and satellite cell behaviour, alongside continued 
development of quantitative individual fiber type/isoform specific protein phosphorylation via 
flow cytometry. 
By understanding the intricate mechanisms underpinning skeletal muscle hypertrophy and 
atrophy, we will also inform the practical use of electrical stimulation to generate assisted 
exercise in human clinical and rehabilitation settings, with our collaborators at the University 
of Vienna and the Swiss Paraplegic Centre Nottwil. This research will ultimately show how 
muscle mass is increased through the transfer of mechanical stimuli into molecular level, 
biochemical changes in mTOR signaling. Identifying and understanding these mechanisms is 
critical to inform future research on interventions that attempt to capitalise on the potency of 
mechanical stimuli for use in clinical settings, to reverse or prevent the loss of muscle 
associated with obesity, cardiac disease, muscular dystrophies, cancer cachexia and ageing.  
This is particularly important when heavy resistance exercise is not safe or feasible and 
therefore alternative interventions are required. 
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